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ABSTRACT 
 Retroviruses recruit viral and cellular RNAs into assembling virions.  This 
dissertation addresses where and how RNAs are first recruited in cells by the retrovirus 
Moloney murine leukemia virus (MLV).  Although differences exist between retroviruses, 
findings in MLV may further our understanding of RNA recruitment by other 
retroviruses, such as human immunodeficiency virus type 1 (HIV-1). 
MLV recruits high levels of cellular noncoding mouse Y RNAs (mY RNAs), the 
RNA component of Ro ribonucleoproteins (Ro RNPs).  In cells, Ro RNPs likely function 
in noncoding RNA quality control.  The Ro60 protein is the main protein component of 
Ro RNPs.  Ro60 knockout mouse embryonic fibroblasts (MEFs) contain ~30-fold less 
mY RNAs than wild type MEFs.  Residual mY1 RNAs in Ro60 knockout MEFs were 
redistributed between the nucleus and cytoplasm, in contrast to the mostly cytoplasmic 
localization of mY1 RNAs in wild type MEFs.  Suprisingly, virions from Ro60 knockout 
MEFs continued to package high levels of mY RNAs.  Together, these data suggest that 
MLV recruits mY RNAs early in their biogenesis. 
Work performed here also addressed where MLV genomic RNAs (gRNAs) are 
first recruited.  Here, specific tetracycline-regulated repression of MLV expression 
produced a more rapid decline in gRNA packaging than virion production. This is 
consistent with previous actinomycin D studies, and it suggests that MLV unspliced 
RNAs bisect into non-equilibrating pools of mRNAs and gRNAs.  Additionally, 
transcription inhibition increased the randomness of gRNA dimer partner associations 
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and recombination rates, with residual biases consistent with ongoing partitioning 
between mRNAs and genomes.  These observations support a model of nuclear MLV 
gRNA dimerization that functions as an initial step in recruitment. 
Work reported here also addressed how MLV gRNAs are first recruited.  
Mutations to the gRNA packaging signal (Ψ), which stabilize Ψ stem loops and disrupt 
dimerization and nucleocapsid (NC) binding in vitro, led to ~100-fold decrease in gRNA 
packaging in a tissue culture system.  This supports an RNA switch mechanism whereby 
dimerization exposes high affinity NC binding sites that recruit the gRNA into 
assembling virions.   
Overall, findings in this dissertation suggest that MLV initially recruits cellular 




Retroviruses are large ribonucleoproteins (RNPs) composed of viral proteins and 
both viral and cellular RNAs.  The viral RNA component of the retroviral RNP is a pair 
of unspliced sense-stranded RNAs, which function as the retroviral genomic RNA 
(gRNA).  Unspliced viral RNA also functions as mRNA in the production of Gag and 
Gag/Pol polyproteins, which constitute the protein components of the retroviral RNP.  
The cellular RNAs that are recruited into retroviral RNPs at levels in excess of their 
abundance in host cells are predominantly noncoding RNA Polymerase III transcripts 
(149).  Why retroviruses package these cellular RNAs and the function of these RNAs in 
retroviral replication is largely unknown.  This dissertation works towards this knowledge 
by attempting to uncover where viral and cellular RNAs are first recruited.  Assembly of 
retroviral RNPs culminates at host cell membranes (41), but the recruitment of RNAs into 
subassembly RNPs may occur earlier (160). 
Work performed in this dissertation addresses the question of where viral and 
cellular RNAs are first recruited by Moloney murine leukemia virus (MLV), where viral 
and cellular RNAs first become part of an MLV RNP.  This dissertation also explores the 
mechanisms of how viral and cellular RNAs are incorporated into the MLV RNP.  
Chapter I is an overview of the MLV RNP and the current knowledge in the field that 
provided the foundation for our study of how and where MLV gRNAs and noncoding 
host cell mY RNAs are first recruited into the MLV RNP. 
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The MLV RNP 
As mentioned above, retroviruses may be viewed as large RNPs.  While retroviral 
particles represent a cell-free form of the retroviral RNP, this dissertation details our 
work on earlier subassembly forms of the retroviral RNP.  In this context, this 
dissertation takes the view that retroviral recruitment of RNA is defined as the initial 
routing of RNA into a subassembly retroviral RNP that precedes budding and maturation 
into cell-free retroviral RNPs.  The point of initial routing of RNAs into retroviral RNPs 
likely differs among retroviruses.  The overall goal of this dissertation was to better 
understand where and how RNAs first become recruited into subassembly retroviral 
RNPs by one retrovirus, MLV.  This dissertation describes our work on the initial 
recruitment of cellular non-coding Y RNAs and the unspliced MLV gRNA into the MLV 
RNP.   
Prior to a discussion of background relevant to retroviral RNA recruitment and 
subcellular RNA trafficking, the following beginning sections will provide a brief 
overview of the main RNA and protein components that make up the MLV RNP. 
MLV RNAs 
  MLV unspliced RNA is an 8.3 kb transcript that is capped and polyadenylated 
(184) (Fig. 1-1A).  Sense-stranded MLV unspliced RNAs function as retroviral genomes 
(gRNA) and as mRNAs in the translation of retroviral proteins.   Full length transcripts 
contain a cis-acting packaging signal, called psi (Ψ), downstream of the 5’ splice donor 
(SD).  The Ψ sequences mediate specific recruitment and incorporation into assembling 




Figure 1-1. MLV RNAs and RNPs. (A) The main MLV RNAs are the unspliced RNA 
and spliced env mRNA. Locations are given for the “classic” Ψ (in red) and the splice 
donor (SD) and splice acceptor (SA).  The arrow indicates the start of transcription of 
viral RNAs by RNA polymerase II at the 1st base of the 5’ R (direct repeat).  The provirus 
long terminal repeats at either end contain U3 (3’ unique) and U5 (5’ unique) sequences 
which are shaded in the lines that represent the RNA transcripts.  The protein products of 
the MLV unspliced RNA are listed below the RNA:  Gag/Pol, Gag, and glycosylated or 
glyco-Gag (gGag).  Gag is an acronym for group-specific antigen and Pol refers to the 
polymerase proteins.  The protein product of the spliced env transcript is also shown – 
Env (envelope).  (B) The proteolytic products of Gag/Pol and the amino-terminal 
myristate (Myr).  Listed domains are:  matrix (MA), the p12 late domain, capsid (CA), 
nucleocapsid (NC) (shaded blue), protease (Pro), reverse transcriptase (RT), and 
integrase (IN).  The drawing is not to scale. 
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unspliced RNA trafficking are discussed in greater detail in subsequent sections of this 
Chapter. 
Subgenomic RNAs also function in MLV replication.  Splicing and removal of 
the Ψ-containing sequences produces a subgenomic transcript for env which codes for the 
MLV ecotropic envelope glycoprotein (Fig. 1-1A).   Alternative splicing also produces 
low levels of a 4.4 kb Ψ-containing subgenomic transcript (40).   An alternative SD site, 
termed SD’, in the capsid sequence of gag is spliced to the same splice acceptor SA that 
produces the env transcript (40).  This alternative splice product is present at 
approximately 8% of full length unspliced transcript levels (83).  Because it includes Ψ, 
this alternative splice product is packaged relatively efficiently at ~5% of the levels of 
full length transcript (83). The alternative splice product is capable of forming 
heterodimers with the full length MLV unspliced RNA, which may affect packaged 
gRNA dimer populations and recombination (120). 
MLV ribonucleoproteins. 
 The full length MLV unspliced RNA is translated into Gag/Pol, Gag, and glyco-
Gag (27) (Fig. 1-1A).  Readthrough of an amber UAG stop codon, which occurs about 
5% of the time, produces the Gag/Pol polyprotein (27).  Rare use of a CUG codon 
upstream of the Gag AUG start codon produces a larger glycosylated form of Gag, called 
glyco-Gag, whose function in MLV replication is not fully understood (47), but recent 
observations suggest a function in viral release through lipid rafts in the plasma 
membrane (140).  The p12 late domain of Gag functions in the release of budding virions 
from the host cells (41).  After budding from host cells, proteolytic maturation of MLV 
Gag and Gag/Pol produces the MLV cleavage proteins.  Cleavage of Gag yields matrix 
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(MA), the p12 late domain, capsid (CA), and the nucleocapsid (NC) protein (Fig. 1-1B 
and Fig. 1-2).  MLV Pol is cleaved to the enzymatic proteins:  protease (Pro), reverse 
transcriptase (RT), and integrase (IN) (Fig. 1-1B and Fig. 1-2).  As mentioned above, 
spliced-env mRNA is translated into the MLV ecotropic envelope glycoprotein. 
As part of the Gag polyprotein, the RT and NC domains function in the 
recruitment of RNAs into virions, and therefore, they likely nucleate formation of the 
retroviral RNP.  RT functions in the incorporation of tRNAPro (109, 110) which primes 
minus strand DNA synthesis during reverse transcription.  NC has nucleic acid chaperone 
functions, and it likely participates in both specific and nonspecific RNA incorporation 
into virions (170).  Human immunodeficiency virus type 1 (HIV-1) minimal virus-like 
particles (VLPs) (1), where NC is replaced with a leucine zipper, reportedly appear to be 
devoid of RNA (30); however, ongoing studies in our lab indicate that the host cell RNA 
7SL is packaged but processed within the VLP (Keene and Telesnitsky, in preparation). 
These VLPs lack the NC domain but retain the carboxy terminal domain of CA-p2 and a 
P-P-P-P-Y late domain motif (P, proline and Y, tyrosine) (1).  This suggests that, in 
addition to NC and RT, the CA domain of Gag may function in the incorporation of RNA 
into assembling virions.  RNA, but not necessarily viral RNA, is necessary for retroviral 
assembly (132). 
Co-packaged host cell RNAs 
MLV selectively recruits a number of host cell noncoding RNAs (149).  Among 
the cellular noncoding RNAs most highly packaged by MLV are tRNAPro, U6 snRNA, 
7SL RNA, and the mY RNAs (149).  The tRNAPro serves to prime minus-strand DNA 




Figure 1-2.  Diagram of mature MLV virion.  MLV proteins are represented and 
labeled in the virion.  The genomic RNA (gRNA) dimer is represented by the black 
squiggly lines in the center of the particle.  Where the two gRNAs intersect is a 
representation of the dimer linkage site between the two sense stranded gRNAs.  The 
dark gray outer circle depicts the lipid envelope that the virion acquires while budding 
from the cell’s plasma membrane.  The loops on the outside of the virus represent the 
MLV Env which is cleaved by the host protease, furan, into a surface unit (SU) and a 
transmembrane domain (TM), which is outlined in white.  Co-packaged host cell RNAs 
are not represented in this figure, and the dimeric RNA genome is stylized to depict the 
dimer linkage near the 5’ end.  In the virion, the long gRNA is more likely wrapped like 
the “inside of a baseball” within capsids.  The drawing is not to scale. 
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functions and manner of recruitment of other noncoding RNAs in MLV replication are 
relatively unknown. 
 MLV packages about one copy per virion of noncoding U6 snRNAs (149).  
Selective packaging of U6 snRNAs has also been reported in Rous sarcoma virus (RSV) 
(67) and HIV-1 (84).  U6 snRNAs function in cells in the formation of the spliceosome 
and in the splicing of pre-mRNAs (208).  U6 snRNAs form an initial snRNP with U4 
RNAs in the host cell nucleus (4).  Although U6 snRNAs are localized to and function in 
the host cell nucleus, they are recruited at high levels into MLV particles (149) which 
assemble and bud from the cell’s plasma membrane (41, 179).  This suggests that these 
RNAs are recruited into a subassembly viral RNP earlier in their biogenesis. 
One of the most highly packaged noncoding RNAs by MLV is 7SL RNA (149).  
7SL RNA is packaged into MLV particles in proportion to retroviral proteins (149, 174).  
As the RNA component of cellular signal recognition particles (SRP), 7SL RNA 
functions in the trafficking of nascent polypeptides to the endoplasmic reticulum (89).  
Packaging of 7SL has been observed in other retroviruses including RSV (16) and HIV-1 
(150).  In HIV-1, 7SL RNA is incorporated without the cellular 54 kd SRP protein (150).  
This suggests that 7SL may be recruited into retroviral particles from a pool of RNAs that 
are not associated with the 54 kd SRP protein and perhaps other SRP proteins. 
High levels of the cellular mY1 and mY3 RNAs are recruited into MLV particles 
(149).  In cells, mY RNAs are in RNPs with the Ro60 host cell protein, and they likely 
function together in the recognition and quality control of misfolded RNAs (24, 142, 171, 
197).  Y RNAs localize with the Ro60 protein to the host cell cytoplasm (141, 156).  
HIV-1 virions package lower levels of Y RNAs than MLV.  However, one study used 
 7
 
RT-PCR analysis to demonstrate increased packaging of hY1, hY3, and hY4 in Ψ- HIV-1 
particles with decreased gRNA packaging, compared to Ψ+ particles (91).  This suggests 
that retroviral recruitment of Y RNAs may intersect with how retroviral genomic RNAs 
are recruited by the virus. 
MLV replication cycle 
MLV replicates its RNA genomes via proviral DNA intermediates (Fig. 1-3).  The 
early steps of the viral replication cycle involve attachment of virions and entry of viral 
RNP components into host cells, immediately followed by reverse transcription to 
generate retroviral DNA from the RNA genome, translocation of the DNA to host cell 
nuclei, and integration into cellular chromosomes to form a provirus (Fig. 1-3).  The late 
events of MLV replication begin with transcription of the unspliced MLV RNA (Fig. 1-3).  
MLV unspliced RNAs are exported out of the nucleus and function as mRNAs in the 
translation of retroviral proteins and as gRNAs that are recruited into assembling virions  
(Fig. 1-3).  MLV assembly takes place at the host cell’s plasma membrane.  After 
budding from host cells, MLV virions undergo proteolytic maturation whereby the Gag 
and Gag/Pol polyproteins are cleaved by the viral protease into their constituent proteins 
(Fig. 1-3). 
Mechanism of MLV gRNA recruitment 
 Retroviral RNAs are recruited in pairs, and this suggests that the mechanism for 
recruitment is coupled with RNA pair associations.  All retroviruses except the 
spumaretroviruses package two gRNAs (36).  Where retroviral gRNAs form dimer 




Figure 1-3.  MLV replication cycle.  The main steps of the MLV replication cycle are 
designated with particular focus on the unspliced viral RNA.  Early events span 
attachment through integration.  Late events, which are the focus of this dissertation, 
begin with transcription and culminate in a mature MLV particle.  The diagram depicts 
the two main functions of MLV unspliced RNA, mRNA for translation and gRNA for 
packaging.  The diagram of the replication cycle also depicts one of the main hypotheses 
tested in this dissertation, that MLV gRNAs form nuclear dimer partner associations.  
These nuclear gRNA dimer partner associations may function to partition MLV unspliced 
RNAs into separate pools of dimeric gRNAs and monomeric mRNAs.  The focus of all 
of the work presented in this dissertation is on the events of viral RNP formation, from 
transcription through budding and maturation.  In the context presented here of MLV as a 
retroviral RNP, the replication cycle depicts how MLV is a dynamic complex of nucleic 
acids and proteins.  The mature virion is, therefore, only one form of the dynamic MLV 




acting sequences involved in dimer initiation affects the frequency of heterodimer co-
packaging and recombination, which suggests that gRNA dimerization likely precedes 
packaging (123, 127, 165).  This, possibly weak (193), initial association becomes more 
stable after budding from the host cell and virion maturation (58, 81).  Reflecting the link 
between gRNA dimerization and packaging, MLV gRNA sequences that are involved in 
dimer initiation and packaging are located in the 5’ UTR within Ψ. 
MLV cis-acting gRNA packaging elements 
 Cis-acting sequences that function in unspliced gRNA packaging are located 
within the 5’ UTR of MLV unspliced RNA (168).  A deletion of ~ 350 bases (b) in the 5’ 
UTR abrogates MLV gRNA packaging (115), and relocation of these sequences to the 3’ 
end of MLV RNAs or heterologous RNAs confers packaging into MLV particles (2, 114).  
This region is referred to here as the “classic” Ψ.  A smaller segment of 64 b within the 
“classic” Ψ region has been demonstrated to be sufficient to confer packaging of 
heterologous RNA, and it has been termed the core encapsidation signal (CES) (bases 
310 to 374, which includes SL-C and SL-D) (Fig. 1-4A) (129).  While the CES is 
sufficient to achieve packaging of heterologous RNAs, the inclusion of downstream 
sequences that encompass the full “classic” Ψ and continue into sequences in the 5’ 
portion of gag leads to increased titers of gene transfer vectors, which suggests that this 
region functions as an extended packaging signal (sometimes referred to as Ψ+) (10, 153).  
The relatively efficient packaging of a MLV cryptic splice product that lacks the 
“classic” Ψ region has provided additional support for the function of sequences 
surrounding the “classic” Ψ in RNA packaging (153). Finally, a small stretch of 17 b 
downstream of the env stop codon also appears to function in RNA packaging, as a 
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deletion of these bases leads to a 10-fold decrease in titer and a 20- to 30-fold decrease in 
gRNA packaging (227). 
MLV gRNA dimerization 
 The MLV dimer linkage site (DLS) is located near the 5’ end of MLV gRNA 
dimers (74).  Retroviral DLS linkages are visible in virion-extracted RNA dimers by 
electron microscopy (11, 100, 112, 134).  The same cis-acting Ψ sequences above which 
have demonstrated functions in packaging also function in gRNA dimerization.  In vitro 
transcribed Ψ sequences spontaneously form dimers at high concentrations in a NaCl-
dependent manner, and purified NC can catalyze this RNA dimerization in vitro (154, 
162).  Computer predictions, phylogenetic analysis, chemical accessibility mapping, and 
mutagenesis have lead to a secondary structure model of stem loops that make up the 
MLV Ψ (Fig. 1-4A) (3, 97, 206).  Nucleotides (nts) 204 to 228 and 283 to 298 function as 
a bipartite signal in MLV gRNA dimer initiation and are called DIS-1 and DIS-2, 
respectively (Fig. 1-4A) (111).   MLV gRNA dimerization initiates through  
intermolecular base pair “kissing” interactions between DIS loops on separate gRNAs 
(Fig. 1-4B) which likely precede the formation of more stable intermolecular interactions 
in an extended dimer interface (Fig. 1-4C) (58, 111). 
MLV NC function in gRNA recruitment 
 The MLV NC domain of Gag functions in the recruitment of MLV gRNAs (168).  
The importance of NC in MLV unspliced gRNA recruitment was first demonstrated by 
mutations in NC, and specifically the zinc finger domain of NC, that disrupt viral 
infectivity and gRNA packaging (72, 121).  NC binds with high affinity to Py-Py-Py-G 




Figure 1-4.  MLV Ψ – kissing complex and extended dimer.  (A) The secondary 
structure of Ψ-associated stem loops with designations for the stem loops that have 
demonstrated functions as sites of dimer initiation (DIS-1 and DIS-2) and as a core 
encapsidation signal (CES)(SL-C and SL-D).  (B) Horizontal lines in the center indicate 
intermolecular base pair “kissing” interactions that function in dimer initiation between 
separate gRNAs (black and gray) Adapted from Ly and Parslow (111).  (C). Depiction of 
a more thermostable “extended” dimer structure.  Lines indicate predicted structure 
stabilizing intermolecular “kissing” interactions between SL-C and SL-D stem loops on 




context of full length Gag, a yeast three-hybrid study of MLV RNA-protein interactions 
suggests that the complete MLV RNA sequence from DIS-1 thru SL-D is important for 
strong Gag-RNA interactions (50).  Further inferences from NMR structural observations 
of NC-RNA interactions suggest that MLV RNA dimerization may function to switch the 
RNA into a conformation that exposes high affinity NC binding sites on the dimeric RNA 
(34, 36, 37).  In this manner, MLV gRNA dimerization functions as an RNA switch into 
a packaging-competent RNA fold (36). 
Subcellular location of initial retroviral gRNA recruitment 
Different retroviruses likely recruit gRNA from different subcellular locations.  
The cis-packaging of Line-1 retroelements (99, 214) and HIV-2 unspliced RNAs (76, 88) 
likely reflects a cytoplasmic point of initial recruitment from a microdomain near sites of 
translation.  HIV-1 unspliced RNAs can be packaged in trans which suggests the 
potential for recruitment from a cellular site distinct from translation (88).  A portion of 
RSV Gag molecules have been observed to traffic through the host cell nucleus and 
disrupting this trafficking impairs gRNA packaging (64), which suggests the potential for 
initial gRNA recruitment from the nucleus (176). 
Retroviral unspliced RNA response to actinomycin D 
Studies using actinomycin D (ActD) as a general transcription inhibitor have 
revealed differences in viral unspliced RNA sorting as mRNA or gRNA by different 
retroviruses.  ActD treatment of MLV producing cells leads to a more rapid decline in 
packaged MLV gRNAs than virion-producing mRNAs, which suggests that MLV 
gRNAs and mRNAs exist in separate non-equilibrating pools (122).  Hence, MLV 
gRNAs are likely recruited from sites distinct from sites of translation.  
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 In contrast, HIV-1 and HIV-2 packaged gRNA levels decline at a similar rate as 
intracellular viral mRNA after ActD treatment, which suggests a single pool of viral 
unspliced RNAs (43).  Similar to HIV-1 and HIV-2, ActD treatment of RSV producing 
cells leads to similar rates of decline in packaged gRNA and intracellular viral RNA 
(198); however, competition between Gag and ribosomes for an RNA structure upstream 
of RSV gag suggests that Gag autogenously regulates whether an RNA is encapsidated or 
translated (194).  Thus, the location of RSV gRNA initial recruitment may vary as a 
function of intracellular Gag concentrations. 
Cellular response to general transcription inhibition with ActD 
 General transcription inhibition with ActD has provided insights into retroviral 
RNA trafficking, but ActD can have indirect effects on cellular physiology and RNA 
trafficking.  These indirect effects may lead to the observed differences in retroviral 
responses to general transcription inhibition with ActD.  Used as a general transcription 
inhibitor, ActD can cause global changes in cellular physiology that lead to apoptosis (69, 
95).   
 ActD can also have more specific off target effects on RNA trafficking which are 
well documented.  General transcription inhibition with ActD disrupts the stability of 
cytoplasmic mRNA processing bodies (P bodies) (29), (212), reviewed in (49).  P bodies 
are sites of mRNA decay and are therefore dependent on RNA availability (5, 29, 182, 
202), reviewed in (49).  Cougot et al. (29) used GFP fusion proteins to show that 
decapping-enzyme subunit hDcp1a-containing bodies disappear after treatment with 
ActD in HEK293 cells.  The indirect disruption of P bodies by ActD transcription 
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inhibition was also observed by Wang et al. (212) in 293T cells by indirect 
immunofluroescense for the P body marker DDX6 (RCK/p54), a decapping co-activator. 
 ActD has also been shown to indirectly alter nuclear import of the influenza viral 
nucleoprotein and the nuclear-cytoplasmic shuttling of a number of cellular proteins.  
Transcription inhibition by ActD disrupts the nuclear translocation of incoming viral 
RNPs from influenza virus as measured by in situ hybridization for vRNA and indirect 
immunofluorescence for the virion nucleoprotein (209).  In addition, GFP-protein fusions 
and indirect immunofluorescence have been used to show that ActD disrupts the normal 
nuclear-cytoplasmic trafficking of cellular proteins.  Human-mouse heterokaryon 
experiments have shown that ActD treatment accelerates the nuclear-cytoplasmic 
shuttling of a heterogeneous nuclear ribonucleoprotein (hnRNP), the polypyrimidine tract 
binding protein (PTB/hnRNP I) (86).  PTB reached equilibrium between mouse and 
human nuclei faster when Pol II and Pol III transcription were disrupted, which suggests 
that RNA binding is not necessary for PTB nuclear export and that RNA binding slows 
its nuclear export and subsequent import (86).   
General transcription inhibition with ActD was used to classify whether the 
nuclear transport of other hnRNPs is dependent on or independent of transcription (159).  
The hnRNP proteins A1, A2, B1, B2, E, H, and L are abnormally retained in the 
cytoplasm after transcription inhibition (159).  ActD also induces the cytoplasmic 
accumulation of JKTBP1 and JKTBP1Δ6 hnRNPs in HeLa cells (87).  Therefore, their 
transport to the nucleus may be classified as transcription-dependent (159).  In contrast, 
hnRNP C retains nuclear localization after transcription inhibition (159).  Hence, its 
nuclear localization was classified as transcription independent (159).   
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Random and nonrandom retroviral gRNA dimer populations 
The packaged gRNA dimer populations that result from co-expression studies 
also reveal differences among retroviruses, which also suggest different sites of initial 
gRNA recruitment.  Our lab and others have demonstrated that co-expressed HIV-1 
gRNAs randomly associate (53, 127).  In combination with the observations of HIV-1 
unpsliced RNAs post ActD treatment mentioned above, this suggests recruitment from a 
single pool of unspliced RNAs in the host cell cytoplasm.  The random association of 
gRNAs expressed from separate nuclei in a cell fusion assay further supports this notion 
of cytoplasmic initial recruitment for HIV-1 gRNAs (126). 
Co-expressed MLV gRNAs exhibit preferential self association, which supports 
an earlier point of initial gRNA recruitment for MLV than HIV-1 (53, 92, 166).  
Consistent with this hypothesis, MLV gRNAs that were expressed from a single nuclear 
locus formed dimer partner associations randomly (54).  In combination with the 
observations of MLV unspliced RNAs post ActD treatment, these data suggest that MLV 
unspliced RNAs are subject to nuclear dimer partner associations that function in the 
bisection of MLV unspliced RNA to function as dimeric gRNAs or monomeric mRNAs. 
Differences between HIV-1 and MLV in the randomness of gRNA dimerization 
are also reflected in differences between the two viruses in the levels of recombination in 
co-expression recombination assays (52, 151, 228).  HIV-1 recombination is about ten-
fold more frequent than MLV recombination (147).  Onafuwa et al. (151) demonstrated 
that HIV-1 and MLV RT enzymes had similar rates of template switching, and thus could 
not account for differences in recombination.  Rather, the differences in recombination 
could be fully accounted for in differences between HIV-1 and MLV in the levels of 
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heterozygous RNA co-packaging (52, 228).  Therefore, levels of recombination also 
reflect the location of dimer pair formation and initial gRNA recruitment. 
Intracellular RNA trafficking 
 How might MLV unspliced RNAs navigate out of the nucleus and through the 
cytoplasm to sites of assembly on the plasma membrane?  Retroviruses use different 
cellular pathways to traffic gRNAs to sites of assembly and budding.  The 
aforementioned studies of MLV, which support nuclear gRNA dimer partner associations, 
suggest that MLV gRNAs move rapidly and directly through the nucleus to sites of 
assembly on the plasma membrane.  Much remains unknown about how MLV gRNAs 
translocate from the nucleus to the plasma membrane.   
The remaining portion of Chapter I, before the dissertation overview, details how 
other retroviruses navigate viral unspliced RNA out of the nucleus and through the 
cytoplasm.  The limited evidence for MLV unspliced RNA intracellular trafficking is also 
presented in this context.  One of the first steps in the path of gRNA trafficking to sites of 
assembly is nuclear export.  In order to navigate this trafficking step, retroviruses have 
evolved different mechanisms to hijack host cell machinery.   
Cellular mRNA nuclear export 
The nuclear export of most cellular mRNAs depends upon both 5’-cap addition 
and splicing (90).  During transcription, nascent transcripts are bound by hnRNPs which 
function in various steps in the life of the mRNA, including nuclear export (18).  Some 
hnRNPs, like the hnRNP A/B family, shuttle with the mRNA to the cytoplasm, and other 
hnRNPs, like the large hnRNP K, are retained in the nucleus (45).  The first processing 
step in the life of a nascent pre-mRNA is the addition of a 7-methylguanosine cap to the 
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5’ end (181).  This is followed by splicing which deposits a set of proteins on the mRNA 
termed the exon junction complex (EJC) (18).  In higher eukaryotes, both the 5’-cap and 
the EJC function in the recruitment of the transcription and export (TREX) complex (18, 
90).  TREX is comprised of the THO complex (a transcription elongation complex) and 
other accessory molecules which include UAP56 and Ref/Aly (18).  In spliced mRNAs, 
the THO complex interacts with hnRNPs and EJC components that recruit UAP56, which 
then recruits Ref/Aly (18).  The non-karyopherin heterodimer Nxf1:Nxt1 displaces 
UAP56 and shuttles the mRNA out of the nucleus through the nuclear pore complex 
(NPC) (18). 
In the nuclear export of some unspliced cellular mRNAs, THO complex proteins 
and other hnRNPs recruit UAP56 in the absence of EJC components (18).  As with 
spliced mRNAs, UAP56 recruits Ref/Aly (18).  The Nxf1:Nxt1 nuclear export factor then 
displaces UAP56 and traffics the RNA out of the nucleus (18).  Ref/Aly function has 
been demonstrated in the export of unspliced histone H4 mRNAs (173).  Like unspliced 
histone H4 mRNAs, unspliced retroviral RNAs that use this pathway must circumvent 
the requirement for EJC proteins which are deposited during splicing, as described below. 
Subsets of cellular mRNAs use the karyopherin Crm1/Xpo1 to traffic out of the 
nucleus (18).  This process requires the binding of adapter proteins to mRNAs because 
Crm1 lacks RNA binding activity (18).  Potential adapter proteins have been discovered 
for a few cellular mRNAs that traffic via Crm1, including HuR for the nuclear export of 
spliced Cd83 and unspliced c-fos mRNAs (18).  HuR interacts with adenosine/uridine-
rich elements (AREs) in these mRNAs.  The coordination of specific adapters with 
different transcripts likely represents another level of nuclear export regulation.  For the 
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unspliced retroviral RNAs that use this pathway, viral adapter molecules coordinate 
Crm1 binding and nuclear export. 
Chapter II of this dissertation addresses an intersection in MLV replication with a 
host cell noncoding RNA quality control pathway and mY RNA biogenesis (Fig. 1-5).  
Prior to an introduction of retroviral mechanisms of nuclear export, the following section 
details the current knowledge in the field of cellular Y RNA biogenesis and nuclear 
egress. 
Cellular Y RNA nuclear export. 
Cellular Y RNAs are RNA polymerase III transcripts whose nuclear export likely 
differs from how cellular mRNAs are exported from the nucleus.  Studies of human hY 
RNAs have identified sequences in the stems of the hY hairpins which function in the 
nuclear export of the RNAs (175, 188).  After transcription, Y RNAs are bound by the 
cellular protein La which recognizes 3’ terminal UUU-OH sequences (Fig. 1-5) (33, 156, 
218).  Subsequent to La binding, Y RNAs are bound by the Ro60 protein (Fig. 1-5B) 
(164).  Ro60 binds to the stem of Y RNAs near the 3’ and 5’ ends (Fig. 1-5A) (220).  
Ro60 accelerates Y RNA nuclear export, but La has the opposite effect and slows export 
of Y RNAs (Fig. 1-5B) (188).  Y RNA-La binding is thought to be more stable than other 
noncoding RNA-La interactions (164), and it is not fully known when 3’ end maturation 
of Y RNAs takes place.  Y RNAs mask a nuclear retention signal on Ro60, and Ro60 and 
Y RNAs translocate together as an RNP to the host cell cytoplasm (Fig. 1-5B) (188).  
Competition of adenoviral VA1 RNAs with hY RNAs for nuclear export has provided 
evidence that Y RNAs are exported from the nucleus by the RanGTP-dependent nuclear 
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export factor exportin-5 (79, 80).  Thus, Y RNAs shuttle out of the nucleus using a 
separate pathway than the pathway used for bulk cellular mRNA nuclear export. 
Retroviral unspliced RNA nuclear egress. 
  Different retroviruses use different cellular pathways to translocate their unspliced 
RNA out of the nucleus.  Mason Pfizer monkey virus (M-PMV) uses an RNA sequence 
termed the constitutive transport element (CTE) to affect nuclear export (155).  The CTE 
binds directly to the cellular nuclear export factor Nxf1 (32, 78).  Together, the M-PMV 
unspliced RNA and Nxf1 are shuttled out of the nucleus (32).  Simian retroviruses type 1 
(SRV) also use a CTE to export unspliced RNA via Nxf1 (78, 201, 229).  This mode of 
export entails direct binding of cellular export machinery to RNA elements in retroviral 
unspliced RNAs. 
Other retroviruses use viral accessory proteins as adapters that join retroviral 
unspliced RNA and cellular RNA export proteins.  Human immunodeficiency virus type  
1 (HIV-1) uses the viral Rev protein to export its unspliced RNA from the host cell 
nucleus (31).  Rev localizes to the nucleus after translation and binds to a Rev response 
element (RRE) on HIV-1 unspliced RNAs (31).  Rev recruits Crm1 to transport the RNA 
out of the host cell nucleus (138).  Binding of hnRNP A2 to A2-responsive elements also 
appears to function in Rev-dependent Crm1 nuclear export of HIV-1 unspliced RNA 
(131).  Other viruses that use the Crm1 nuclear export pathway encode similar adapters.  
For example, human T-cell leukemia virus type 1 and type 2 (HTLV-1 and -2) encode the 
Rex adapter which mediates Crm1 export of RxRE-containing HTLV unspliced RNAs 




Figure 1-5.  Model of Y RNA biogenesis.  (A) A secondary structure model of mY1 
RNA with the Ro60 protein bound to the stem of the mY1 RNA near the 5’ end and the 
3’ uridylate tail.  (B) Model for mY1 RNA biogenesis.  Y RNAs are Pol III transcripts 
which are bound by La and subsequently by Ro60 in the nucleus.  Y RNAs mask a 
nuclear retention signal on the Ro60 protein and translocate with the Ro60 out of the host 
cell nucleus.  In cells, most Y RNAs reside in RNPs with the Ro60 protein in the 
cytoplasm. (B) was adapted from the model of Pruijn et al. (164). 
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  A portion of Rous sarcoma virus (RSV) Gag molecules traffic through the nucleus 
en route to sites of assembly, and this may represent a retroviral example of nuclear Gag-
gRNA recruitment (176).  RSV Gag is transported out of the nucleus via the Crm1 
pathway (176, 178).  Disruptions to RSV Gag trafficking through the nucleus impair 
gRNA packaging, which suggests that gRNAs exit the nucleus with Gag via the Crm1 
pathway (64).  First, however, some RSV unspliced RNA must exit the nucleus to 
function as mRNA in the translation of Gag.  Several studies suggest that two direct 
repeats (DRs) which flank the 3’ src gene of RSV function in nuclear export of RSV 
unspliced RNA (145, 146, 189, 224).  Using a RSV DR reporter construct, Leblanc et al. 
(103) demonstrated that this mode of RNA export likely occurs via Nxf1 and the DEAD 
box RNA helicase Dbp5.  This mode of nuclear export was independent of Gag (103).  
Speculatively, this suggests that RSV unspliced RNAs which function as mRNAs and 
gRNAs may traffic out of the nucleus via separate cellular pathways.  However, the low 
level packaging of RSV unspliced RNAs with premature termination codons (PTCs) 
suggests that at least some RSV RNAs may first be translated (102). 
The pathway MLV uses to traffic its unspliced RNA out of the nucleus is 
unknown, but sequences in the 5’ UTR, including portions of Ψ, may function in this 
process.  In the SL3 strain of MLV, mutations to a stem loop in the 5’ R region impaired 
the cytoplasmic accumulation of full length transcripts, but not the accumulation of 
spliced env transcripts (207).  Fusing the 5’ UTR to a reporter, Trubetskoy et al. (207) 
showed that mutation of this R region stem loop (RSL) led to a two-fold decline in 
intron-containing reporter expression but a greater than ten-fold decline in intronless 
reporter expression.  This suggests that the RSL may function in nuclear export of MLV 
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SL3 unspliced RNAs which function as mRNAs.  However, gRNA packaging was not 
addressed in these experiments. 
In addition to the RSL, the RNA stem loops associated with MLV Ψ may 
contribute to MLV unspliced RNA nuclear export.  Placing the MLV Ψ signal within an 
HTLV-1 expression cassette led to Rex independent reporter expression, which suggests 
that sequences in Ψ provided a nuclear RNA export function (94).  With minimal MLV Ψ 
constructs that contain flanking SD and SA sites, Ψ stem loops associated with 
dimerization and packaging increase cytoplasmic levels of unspliced RNAs relative to 
spliced RNAs in comparison to an RNA lacking these stem loops (192).   Also, minimal 
Ψ-containing RNAs appear to compete with full length MLV unspliced RNAs for nuclear 
export as reported in a co-expression study (192).  With fluorescent in situ hybridization 
(FISH) of tagged MLV unspliced RNAs, Basyuk et al. (7) showed that deletions of 
individual Ψ stem loops disrupted nuclear export of the tagged MLV unspliced RNAs.  
Together these data suggest that MLV Ψ may function in nuclear egress of MLV 
unspliced RNAs. 
The mode of nuclear export used by retroviral unspliced RNAs can affect viral 
assembly and gRNA sorting.  Changing the mode of HIV-1 nuclear export from the 
Crm1 pathway to the Nxf1 pathway relieves the restriction of HIV-1 assembly in murine 
cells (200).  Also, co-expressing HIV-1 gRNAs that either use Crm1 or Nxf1 for nuclear 
export decreases levels of recombination between the two co-expressed gRNAs (128).  
These observations suggest that the mode of nuclear export affects downstream functions 
of retroviral unspliced RNAs and partitioning within the cytoplasm. 
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Retroviral cytoplasmic unspliced RNA trafficking  
Different retroviruses use different mechanisms to sort and regulate the trafficking 
of their unspliced RNA within the host cell cytoplasm.  Trafficking of retroviral 
unspliced RNAs to microdomains within the cytoplasm can regulate whether the RNA 
functions as gRNA or mRNA.  Retroviruses can co-opt cellular cytoplasmic trafficking 
machinery to move viral unspliced RNA to different microdomains within the cytoplasm 
(199). 
A perinuclear/pericentriolar area termed the microtubule-organizing center 
(MTOC) may represent a cytoplasmic microdomain where M-PMV and HIV-1 gRNAs 
are routed while trafficking to sites of assembly (135, 199).  A cytoplasmic targeting-
retention signal (CTRS) in M-PMV MA traffics nascent Gag molecules to the MTOC 
(180).  Sfakianos et al. (180) observed ribosomes and polyribosomes in the vicinity of 
assembling immature capsids at the MTOC.  Also, cycloheximide treatment depleted Gag 
localization at the MTOC more rapidly than nocodazole treatment, which suggests that 
Gag translation is ongoing at the MTOC (180).  Together, these data may suggest that M-
PMV has a cis-packaging preference for gRNAs at the MTOC.   
HIV-1 RNAs do not exhibit a cis-packaging preference, but confocal microscopy 
observations of fluorescence energy transfer (FRET) between HIV-1 Gag molecules and 
HIV-1 unspliced RNAs at the MTOC suggest that this may represent the site of initial 
recruitment of HIV-1 gRNAs during assembly (160).  HIV-1 unspliced RNA trafficking 
to and from the MTOC appears to be partially regulated by hnRNP A2, as knockdown of 
this cellular hnRNP results in the rapid nuclear export and accumulation of HIV-1 
unspliced RNAs at the MTOC (106). 
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Cytoplasmic mRNA processing bodies (P bodies) may function as another 
microdomain in retrovirus unspliced RNA cytoplasmic trafficking.  P bodies are sites of 
RNA storage and 5’ to 3’ RNA degradation (49, 118).  Yeast Ty3 RNAs, proteins, and 
VLPs co-localize with P body proteins, and knockout of P body proteins decreases Ty3 
retrotransposition (9).  This suggests that Ty3 uses this cytoplasmic RNA quality control 
pathway as a microdomain for assembly and RNP formation.  Retroviruses might use P 
bodies or P body proteins to stall translation and re-route unspliced RNAs towards sites 
of assembly and packaging. 
How MLV gRNA navigates through the cytoplasm is relatively unknown, but one 
study has reported MLV gRNA trafficking on endosomal vesicles (8).  Basyuk et al. (8) 
used live cell imaging of MS2-GFP bound to MS2-binding site-containing MLV RNAs 
to show colocalization of these RNAs with transferrin-positive endosomes.  This 
localization required both Gag and Env proteins (8).  This suggests that vesicular 
trafficking may function in the movement of MLV RNPs to sites of assembly at the 
plasma membrane, and may therefore represent a subassembly microdomain in MLV 
replication. 
The localization of retroviral proteins and RNAs to and from cytoplasmic 
microdomains suggests retroviruses co-opt microtubule motor proteins to move viral 
RNP cargos throughout the cell.  Knockdown of the microtubule plus-end-directed 
kinesin motor protein KIF4 disrupts HIV-1 particle production, slows cytoplasmic 
trafficking of Gag, and leads to increased Gag degradation (117).  Upon Kif4 knockdown, 
Gag colocalized with a perinuclear marker which has also been shown to colocalize with 
M-PMV Gag (117, 215).  This suggests that the KIF4 microtubule motor protein may 
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function in cytoplasmic HIV-1 Gag trafficking.  A yeast two-hybrid screen revealed a 
carboxy-terminal KIF4-MLV Gag interaction that was also demonstrated by in vivo pull 
down assays (93).  Therefore, KIF4 may also function in MLV Gag cytoplasmic 
trafficking towards the plasma membrane in a microtubule plus-end directed fashion. 
An interaction of MLV MA with IQGAP may also function in Gag-cytoskeleton 
interactions in MLV RNP trafficking.  The cellular proteins IQGAP1 and IQGAP2 bind 
directly to actin (60), and they modulate cytoskeletal rearrangements (61, 213).  Yeast 
two-hybrid analysis revealed an MLV MA-IQGAP interaction (105).  Overexpression of 
a C-terminal fragment of IQGAP1 inhibited MLV release, and shRNA knockdown of 
IQGAP1 and/or IQGAP2 decreased viral spread (105).  This suggests that Gag MA 
interactions with IQGAP1 are also important for late Gag trafficking steps. 
The double-stranded RNA-binding protein Staufen may function in the 
cytoplasmic trafficking of retroviral unspliced RNAs.  Staufen is a dsRNA-binding 
protein that functions in RNA localization in Drosophila (195).  The human and mouse 
orthologs bind dsRNA and tubulin in vitro, and they localize to the endoplasmic 
reticulum (216).  Human Staufen I (hStau) copelleted with HIV-1, HIV-2, and MLV 
virions, and it co-sedimented with HIV-1 viral proteins and RNA on sucrose density 
gradients (130).  Incorporation of hStau into HIV-1 particles also correlated with levels of 
HIV-1 gRNA incorporation (130).  Subsequent studies in HIV-1 demonstrated an 
interaction between the HIV-1 NC zinc fingers and the double-stranded RNA binding 
domain of hStau (20, 21).  Thus, mounting evidence suggests a function for Staufen in 
HIV-1 gRNA recruitment, and its incorporation into MLV particles may suggest a similar 
function in MLV. 
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 The preliminary observations mentioned above suggest that cellular proteins like 
KIF4, IQGAP, and Staufen may function in MLV unspliced RNA cytoplasmic trafficking 
through interactions with the host cell cytoskeleton.  However, the differences in 
unspliced RNA sorting and trafficking between MLV and other retroviruses like HIV-1 
described in previous sections suggest that where and when the MLV RNP first 
encounters these cellular proteins may differ from other retroviral RNPs.  Prior studies 
and observations reported in this dissertation suggest that cellular mY RNAs and MLV 
gRNAs are routed towards sites of assembly prior to nuclear egress.  Thus, early 
recruitment of these proteins to the MLV RNP as it exits the nucleus could provide a 
means of directly navigating from the nucleus to sites of assembly. 




This dissertation addresses the question of where RNAs are first recruited for 
assembly by MLV.  To address this question and test the hypothesis that cellular Y RNAs 
are recruited from the host cell nucleus, Chapter II details our observations of cellular 
mY RNA packaging in MLV virions produced from Ro60 knockout cells, which have 
~30-fold less cellular mY RNAs than wild type cells.  Our observations of high level 
packaging of mY1 and mY3 RNAs in virions from Ro60 knockout cells is consistent 
with our hypothesis that these RNAs form a subassembly retroviral RNP in the host cell 
nucleus.   
Next, Chapter III relates our observations of MLV gRNA packaging to virion 
production after specific tetracycline-repression of MLV transcription.  The results, 
which indicate viral mRNAs have longer half-lives than gRNAs, are consistent with prior 
observations obtained with general transcription inhibition with ActD, and they are 
consistent with our hypothesis that MLV unspliced RNAs are bisected into separate pools 
of gRNA and viral mRNA.  Chapter III also tests the hypothesis that this bisection occurs 
at or near sites of transcription by testing outcomes of inhibiting transcription on the 
randomness of gRNA dimer co-packaging and on recombination in co-expression studies.  
Results again are consistent with our hypothesis of a nuclear bisection, but the moderate 
increases in the randomness of gRNA dimerization and recombination are consistent with 
an ongoing bisection of MLV unspliced RNA. 
In Chapter IV, we address the hypothesis that MLV gRNA dimerization functions 
as a molecular switch to package MLV gRNA.  Our results are consistent with this 
hypothesis, and they provide in vivo support for in vitro observations of high affinity NC-
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RNA interactions that were performed in collaboration with the work discussed here.  In 
Chapter IV, we test the hypothesis that gRNA dimerization represents an initial point of 
recruitment into a MLV RNP subassembly complex.  Our preliminary results are 
consistent with this hypothesis. 
Finally, in Chapter V, our observations of a potential intersection in MLV mY 
RNA and gRNA recruitment are discussed in the context of an additional preliminary 
finding of an inverse relationship between packaged gRNA levels and packaged mY 
RNA levels.  This finding supports the notion of an intersection in MLV gRNA 











 Moloney murine leukemia virus (MLV) selectively encapsidates host mY1 and 
mY3 RNAs. These noncoding RNA polymerase III transcripts are normally complexed 
with the Ro60 and La proteins, which are autoantigens associated with rheumatic disease 
that function in RNA biogenesis and quality control. Here, MLV replication and mY 
RNA packaging were analyzed using Ro60 knockout embryonic fibroblasts, which 
contain only ~3% as much mY RNA as wild type cells. Virus spread occurred at the 
same rate in wild type and Ro knockout cells. Surprisingly, MLV virions shed by Ro60 
knockout cells continued to package high levels of mY1 and mY3 (about 2 copies of each) 
like those from wild type cells, even though mY RNAs were barely detectable within 
producer cells. As a result, for MLV produced in Ro60 knockout cells, encapsidation 
selectivity from among all cell RNAs was even higher for mY RNAs than for the viral 
genome. Whereas mY RNAs are largely cytoplasmic in wild type cells, fractionation of 
knockout cells revealed that the residual mY RNAs were relatively abundant in nuclei, 
likely reflecting the fact that most mY RNAs were degraded shortly after transcription in 
the absence of Ro60. Together these data suggest that these small, labile host RNAs may 
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be recruited at a very early stage of their biogenesis and may indicate an intersection of 




 Retroviruses are ribonucleoprotein (RNP) complexes that assemble at host cells’ 
plasma membranes.  Their predominant RNA component is the unspliced retroviral 
genome, but virions also contain a number of host cell noncoding RNAs (13, 149, 174). 
Subsets of these RNAs are over-represented in virions relative to their abundance in host 
cells (149). Other than the primer tRNA, which anneals to the primer binding site on viral 
genomic RNA (gRNA) and initiates minus-strand DNA synthesis, the manner of 
recruitment of these RNAs and whether or not they function in retrovirus biology is 
unknown (19, 109, 110). Virion assembly does not require viral gRNA, but RNA of some 
sort is required for assembly, thus suggesting host RNA can serve this role (96, 132).  
Although prevailing notions suggest nonspecific RNA interactions drive retrovirus 
assembly (63), the concentration within virions of particular subsets of host cell 
noncoding RNAs suggests that their recruitment may have functional significance for 
viral assembly or other replication processes. 
 Among the most highly recruited noncoding cellular RNAs in MLV are mY1 and 
mY3 (149). These RNAs are enriched in MLV particles to a similar degree as the highly 
packaged 7SL RNA (7S or SRP RNA) (149). Packaging of 7SL RNA, the scaffolding 
RNA of host cell signal recognition particles, is observed for a number of retroviruses 
including Rous sarcoma virus (RSV) (15), MLV (46, 149, 157) and HIV-1 (150). In 
MLV, 7SL is present at three- to four-fold molar excess to gRNA, and therefore 
packaged at approximately six to eight copies per virion (149). HIV-1 particles contain 
roughly 10 to 14 molecules of 7SL per gRNA dimer (150). Like MLV, HIV-1 also 
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packages at least some Y RNAs, albeit at a lower level of enrichment than 7SL (6, 91, 
204).  
 mY1 and mY3 are host RNA polymerase III transcripts of ~100 nucleotides. Both 
these mouse RNAs fold into similar structures consisting of 5’ and 3’ ends joined in a 
base-paired stem surrounding an internal, largely single-stranded, loop (25). Within cells, 
most mY RNAs are complexed with the host cell protein Ro60, which appears to 
function in quality control of misfolded noncoding RNAs (24, 142, 171). Structural 
analysis suggests Y RNA binding may inhibit Ro60 access to misfolded RNAs, as Ro60 
binding sites for Y RNAs partially overlap those for misfolded RNAs (59, 197, 220). In 
agreement with this hypothesis, a bacterial Y RNA inhibits the function of its Ro 
orthologue in 23S rRNA maturation (26).  It has been suggested that Y RNA binding 
might sequester Ro60 in the cytoplasm, thereby preventing Ro60’s interaction with 
nascent nuclear transcripts (142, 164). Consistent with this view, the mouse Ro protein 
was recently shown to contain a signal for nuclear accumulation that is masked by Y 
RNA binding (186). 
 Chapter II includes work published in Garcia et al. (65) that addressed a potential 
intersection in mY RNA biogenesis and MLV virion assembly.  This work builds on the 
initial findings of Onafuwa-Nuga (148) that demonstrated a surprisingly high level of 
mY1 and mY3 RNA packaging in MLV virions from Ro60 knockout cells which lack 
Ro60 and contain ~30 fold less mY RNAs.  Here, the levels of mY1 RNA packaging 
were quantified by RNase protection assays, and results demonstrated that MLV virions 
from Ro60 knockout cells package ~2 copies of mY1 RNA per virion.  Also, 
measurements of mY1 RNA levels in nuclear and cytoplasmic fractions revealed a 
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subcellular redistribution of mY1 RNAs in Ro60 knockout cells.  Finally, analysis of mY 
RNA processing intermediates revealed a lack of bias in the length of mY1 RNAs that 
were packaged by MLV.  Together, these findings support the initial work of Onafuwa-
Nuga (148), and they demonstrate a remarkable degree of selectivity in mY RNA 
encapsidation into MLV particles.  These results also suggest mY RNAs are recruited for 
MLV packaging from a very early stage in their biogenesis. 
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Materials and Methods 
 Cells and virus.  NIH 3T3 and derivative cell lines were maintained in 
Dulbecco’s modified Eagle medium (DMEM; Invitrogen) supplemented with 10% 
bovine serum (Invitrogen). Wild type mouse embryonic fibroblasts (MEFs) and Ro60 -/- 
MEFs were maintained in Dulbecco’s modified Eagle medium (DMEM; Invitrogen) 
supplemented with 10% fetal bovine serum (Gemini).  Wild-type and Ro60 -/- MEFs 
were prepared by backcrossing 129/Sv x C57BL/6 Ro-/- mice (221) with C57BL/6 mice 
for six successive generations (186).  Embryonic fibroblasts were prepared and 
immortalized by repeated passage (205). Wild-type MLV particles were obtained by 
collecting supernatants from 70% to 100% confluent NIH/3T3 cells, wild type MEFs, and 
Ro60 -/- MEFs chronically infected with wild type MLV at 8- to 16-h intervals.  
 Plasmids.  All riboprobe templates were derivatives of pBSII SK(+) (Stratagene).  
pEG604-1 was constructed with synthetic oligos for 95 nt of mY1 (nt 1 to 95) with SalI 
and EcoRI sticky ends and 65 nt of mouse 7SL RNA (nt 125 to 189) with PstI and NotI 
sticky ends.  The insert in pEG467-10, which was generated by PCR and subcloned into 
the EcoRV site, included complementary portions to both the MLV 5’ untranslated 
region (nt 55 to 214) and 100nt of 7SL RNA (149).   
 Viral and cellular RNA extraction.  All supernatants were filtered using 0.2µm 
MCE syringe filters (Fisher Scientific), and stored at -70 ºC prior to use. Virus was 
concentrated at 4 ºC by centrifugation at 25,000 rpm for 90 min using the AH629 rotor in 
a Sorvall discovery ultracentrifuge. Viral pellets were resuspended in TRIzol (Invitrogen), 
and RNA extracted following the manufacturer’s instructions. RNA from chronically 
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infected cells was also extracted with TRIzol. Samples were resuspended in either DEPC-
treated ddH2O or TENS (10 mM Tris [pH 8.0], 1 mM EDTA, 1% SDS, 100 mM NaCl). 
 Northern blots. Northern blots were used to visualize RNAs. Hybridization 
probes were oligonucleotides complementary to the RNAs of interest, 5’ end labeled 
using γ-32P ATP (Perkin-Elmer) and T4 polynucleotide kinase (NEB). Labeled 
oligonucleotides were separated from unincorporated nucleotides on G-25 sephadex 
columns (Roche). Oligonucleotides included: 
5’-CTGACTGTGAACAATCAATTGAGATAACTCACTAC-3’ for mY1;  
5’-CGTGTCATCCTTGCGCAGGGGCCATGCTAATCTTCTCTGT-3’ for U6; 
and 5’-GAGTCCCACGCTCTACCAACTGAGCTAGCTG-3’ for tRNALys1. 
Fractionated cellular RNAs were separated by 8% polyacrylamide-8M urea gel 
electrophoresis in 1X TBE. For high resolution denaturing northerns, viral and cellular 
RNAs were separated on 8% polyacrylamide-8M urea gels (0.4 mm thickness) in 1X 
TBE using glass plates pre-treated with Sigmacote® (Sigma) to facilitate separation from 
the glass plates prior to transfer. RNAs were subsequently transferred by electroblotting 
to Zeta-probe GT Nylon membranes (Bio-Rad) in 0.5X TBE. Membranes were air dried, 
UV crosslinked (Stratalinker; Stratagene), and prehybridized at 45 ºC in 6X SSC-5X 
Denhardt’s solution-0.5% SDS-0.025M sodium phosphate-625µg/ml denatured salmon 
sperm DNA. Oligonucleotide probes were denatured at 85 ºC for 5 minutes before adding 
to the membranes, and hybridization was at 45 ºC.  Blots were washed first in 2X SSC-
0.1% SDS at 52 ºC, and then in 0.33X SSC-0.1% SDS at 52 ºC.  Damp blots were 
wrapped in plastic wrap and exposed to phosphorimager screens and/or film. For re-
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probing, blots were stripped by at least 2 washes in 0.1% SDS at 80 ºC, then 
prehybridized and probed as above. 
 Ribonuclease protection assays.  To detect mY1 and 7SL, pEG604-1 was 
linearized with XhoI and transcribed with T3 RNA polymerase (Promega) and [α-32P] 
rCTP to create a 217 nt transcript which protected 95 nt of mY1 and 65 nt of 7SL RNA.  
To detect 7SL and MLV genomic RNA, pEG467-10 was linearized with HindIII and 
transcribed with T3 RNA polymerase to create a 364 nt transcript which protected 160 nt 
of MLV genomic RNA and 100 nt of 7SL RNA.  Previously described RPA approaches 
[Onafuwa-Nuga, 2005 #8] were modified by extending hybridization times to 16h and by 
digesting with a 5-fold excess of RNase T1 (Applied Biosystems).  Bands were 
quantified by PhosphorImager analysis using a Typhoon for detection and ImageQuant 
TL for analysis.  Bands were adjusted for the number of radiolabelled Cs incorporated. 
 Exogenous RT assay.  Quantification of RT activity of cell-free media 
supernatants was used to measure levels of virus per volume of media.  Media 
supernatants were harvested, filtered through 0.2 μM MCE syringe filters (Fisher 
Scientific) and stored at -70 ºC.  RT assays were based on (70) as described previously 
(203).  Briefly, 3 μl of viral supernatant was incubated with 12 μl of a 1.2x solution (60 
mM Tris [pH 8.3], 24 mM dithiothreitol, 0.7 mM MnCl2, 75 mM NaCl, 0.06% NP-40, 6 
μg/ml oligo(dT), 12 μg/ml poly(rA), 10 μCi/ml [α-32P]TTP at 3 Ci/mmol) at 37ºC for 2 h.  
Following incubation, 3 μl of reaction mix was spotted onto DEAE paper, dried, washed 
with 2xSSC followed by 95% ethanol, and once again dried.  Spots were quantified by 
PhosphorImager analysis.  
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Cellular fractionation.  Wild type and Ro60 -/- MEFs were fractionated using a 
modification of the procedure of Siomi et al. (191). Briefly, nuclear and cytoplasmic 
fractions were obtained by washing adherent cells twice with ice cold 1x phosphate 
buffered saline (PBS) followed by one wash with buffer RSB100 (10 mM Tris-HCl pH 
7.4, 2.5 mM MgCl2, and 100 mM NaCl).  Adherent cells were permeabilized by 
incubation with 4 mls RSB100 supplemented with .01% (w/v) digitonin (Sigma) on ice 
for 5 min.  The RSB100 buffer-digitonin mix was removed from the adherent cells and 
spun at 200 x g for 5 min to pellet residual cell debris.  The RSB100 buffer supernatant 
served as the cytoplasmic fraction, and RNA was extracted from this aqueous mix with 
TRIzol LS (Invitrogen) according to the manufacturer’s recommended protocol.  The 
remaining nuclei were washed once with ice cold PBS before the addition of 1 ml of 




MLV replication is unaltered in Ro60 -/- cells.  
Ro RNP RNAs mY1 and mY3 are among the most highly enriched host RNAs in 
MLV particles (149). Within cells, most Y RNAs exist in RNPs containing the Ro60 
cellular protein, and most Ro60 protein is associated with Y RNAs (156, 219). When Y1 
RNA levels were used to normalize parallel viral and cellular protein extracts, the Ro60 
protein in virus was below the limit of detection by western blot (148).  To test the 
inference that Y RNAs were not recruited as parts of Ro RNPs, the kinetics of viral 
spread and Y RNA recruitment were analyzed in Ro60 knockout cells. 
 Ro60 binding is necessary for the stable accumulation of Y RNAs (23, 101, 221). 
Accordingly, embryonic fibroblasts prepared from Ro knockout mice contain only very 
low levels of mY1 and mY3 (186). Thus, studying MLV infectivity in Ro60 knockout 
cells allowed an examination of the effects of limiting mY RNA availability on viral 
replication, as well as possible roles of Ro60 itself. Ro60 -/- mouse embryonic fibroblasts 
(MEFs) and isogenic wild type cells were infected with MLV, and infected and control 
uninfected cells were serially passaged.  Culture media were collected and assayed for 
reverse transcriptase (RT) activity at various time points post-infection to monitor virus 
spread (Fig. 2-1). Control uninfected cells retained only background levels of RT activity 
throughout the time course. For media samples from wild type and Ro60 -/- infected 
MEFs, the levels of RT activity rose above background on the same day (day 7) (Fig. 2-
1).  Thereafter, the kinetics of virus spread in infected wild type and Ro60 -/- cells 
remained approximately equal, with infected Ro60 -/- supernatants containing levels of 




Figure 2-1.  Time course of MLV spread in Ro60 -/- cells and wild type MEFs.  Wild 
type and Ro knockout cells were infected with identical amounts of MLV, and virus 
spread was monitored by assaying for RT activity at the indicated time points.  (dpi 
designates days post infection) 
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shown).  Thus, Ro60 was dispensable for infectious MLV particle assembly and 
infectivity. 
MLV virions from wild type and Ro60 -/- MEFs package high levels of mY1 and 
mY3.  
Because MLV replicated normally in cells containing very low levels of mY 
RNAs, it initially seemed likely that virions shed from Ro knockout cells would contain 
correspondingly low levels of mY RNAs. Surprisingly, despite the very low levels of mY 
RNAs in R060 -/- cells, MLV virions produced from these cells continued to package 
high levels of mY RNAs (65, 148).  When normalized to the co-packaged 7SL RNA, 
which is undiminished in Ro60 -/- cells, virus produced from the Ro60 -/- cells contained 
nearly the same amount of mY RNA per virion as virus from wild type cells (65, 148). 
 Because the Y/7SL RNA ratios in virus vs. those in cells were the same for both 
mY1 and mY3 RNAs, this suggests that each MLV virion encapsidates the same number 
of mY1 molecules as mY3 molecules.  However, because the previous observations of 
mY RNA per 7SL packaging were obtained by northern blots which involved co-probing 
with two separate oligonucleotide probes--one for mY RNA and the other for 7SL--the 
absolute number of Y RNAs per virion could not be addressed by the radioactive signals 
(65, 148). Thus, to ensure uniformity in probe specific activities and estimate the number 
of mY1 RNAs packaged per virion, virus and cell RNA samples were subsequently 
probed with a single radiolabeled oligonucleotide complementary to both 7SL and mY1. 
The results indicate that approximately two-fold less mY1 than 7SL RNA was 
encapsidated into MLV produced by wild type cells, and slightly less mY1 was packaged 
into MLV produced from Ro60 knockouts (65, 148).  
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Here, ribonuclease protection assays (RPA) for mY1 and 7SL RNA confirmed the 
previous quantification and revealed a near 2:1 ratio of 7SL:mY1 in virus from wild type 
cells (Fig. 2-2A, lane 7).  When normalized to 7SL, a detectable but less than two-fold 
decrease in mY1 packaging was observed in virus from Ro60 knockouts (Fig. 2-2A, lane 
8).  The gRNA to 7SL ratios in virus from both cell types (Fig. 2-2B, lanes 3 and 4) were 
consistent with previously established levels of 7SL packaging (three- to four-fold molar 
excess to gRNA (149)).  Taken together these results indicated that each MLV virion 
from wild type MEFs contained four to five copies of both mY1 and mY3, and virions 
from Ro60 knockouts contained approximately 2 copies of mY1 and mY3. 
The subcellular distribution of mY1 RNA is altered in Ro60 -/- cells. 
Ordinarily, most Y RNA localizes to the cytoplasm, where it is bound to Ro60 in 
RoRNPs (141, 156). The reduced levels of mY RNAs in Ro60 -/- cells are believed to 
reflect their decreased intracellular stability when their cognate RNP protein is not 
present (23, 101, 221). Thus, a reduction in mY RNA stability in Ro60 -/- cells would 
likely be accompanied by a more severe deficit of mY RNA in the cytoplasm than in the 
nucleus.  
 To determine the subcellular distribution of the residual mY1 RNA in Ro60 -/- 
cells, RNA was extracted from total, nuclear and cytoplasmic fractions of knockout and 
isogenic wild type MEFs (Fig. 2-3).  Northern blots were probed for mY1 or co-probed 
for nuclear U6 snRNA and cytoplasmic tRNALys1 to control for fractionation efficiency. 
The results indicated that the cytoplasm of wild type cells contained at least four-fold 
more mY1 RNA than their nuclei (Fig. 2-3A, lanes 3 and 5).  In contrast, nuclear and 




Figure 2-2.  Stoichiometric analysis of mY1 RNA packaging.  (A) RPA of cellular and 
supernatant/viral RNA for mY1 and 7SL RNA.  Lanes show:  undigested probe (P); RNA 
size markers (M); experimental samples indicated at top either Ro60 wt (+/+) or Ro60 
knockout (-/-); and digested probe alone control (C). (B) RPA of supernatant/viral RNA 
for gRNA and 7SL RNA (C).  Quantification of 4 to 5 mY1 RNAs per virion (gRNA 
dimer) was performed by quantifying the bands in two separate RPAs represented in (B), 
correcting for 18 [α-32P] rCTPs for mY1 and 25 [α-32P] rCTPs for 7SL, and multiplying 
by 7.75 7SL RNAs per virion as determined by two separate RPAs represented in (C).  
The bands in (C) were corrected for 53 [α-32P] rCTPs in the MLV gRNA and 35 [α-32P] 
rCTPs in the 7SL RNA.  These data were consistent with quantification by direct MLV 
gRNA per mY1 RPAs performed in triplicate (data not shown). 
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fraction lane contains 10% more Y1 than cytoplasmic fraction; Fig. 2-3A, lanes 4 and 6). 
Compared to wild type cells, knockout cell cytoplasmic amounts of mY1 were reduced 
about 20-fold, and nuclear amounts were reduced about four-fold. Because the nuclear 
levels of the control RNA U6 are not reduced in knockout cells, the fourfold decrease of 
nuclear Y1 in the knockouts suggest at least some of the RNA degradation associated 
with the absence of Ro60 may initiate in the nucleus. These findings confirm a marked 
alteration in the subcellular location of mY RNAs, from their cytoplasmic prominence in 
wild type cells to a far greater depletion from cytoplasm than from nucleus for the 
residual mY RNAs in Ro60 knockout cells.  
 The results here showed mY RNAs were recruited at wild type levels from Ro60 
knockout cells, despite 20 to 30-fold reductions in mY RNA intracellular levels. When 
mY to gRNA ratios in wild type cells and virus are compared, mY RNAs are selected for 
packaging 3 to 4 fold less well than MLV gRNAs (149). Thus, whereas virions produced 
by wild type cells package mY RNAs slightly less effectively than viral gRNAs, when 
MLV replicated in Ro knockout cells, mY1 and mY3 displayed a roughly 5- to 10-fold 
higher packaging selectivity than gRNAs. 
 
mY RNA packaging is independent of Y RNA processing step. 
 The biosynthesis of host ribonucleoprotein complexes involves a series of RNA 
processing steps and alternate protein associations. Significant uncertainty remains about 
both temporal and spatial aspects of these steps in Ro RNP assembly (156, 164, 187, 188, 
218). Nonetheless, it is clear that transcription of Y RNAs, as is the case for all RNA 




Figure 2-3.  mY1 RNA redistribution in Ro60 -/- cells. (A) Northern blot of RNA from 
total (T), nuclear (N), and cytoplasmic (C) fractions of both wild type Ro60 +/+ MEFs 
and knockout Ro60 -/- MEFs, probed for mY1. (B) Northern blot of RNA from total (T), 
nuclear (N), and cytoplasmic (C) fractions of both wild type Ro60 +/+ MEFs co-probed 
for U6 snRNA, a nuclear RNA control, and tRNALys1, a cytoplasmic RNA control.  
Quantification of the levels of mY1, U6, and tRNALys1 are given below each blot as a % 
of total cellular RNA from wild type MEFs (T+/+). 
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are bound by the La protein, which recognizes RNAs ending in three or more uridines (33, 
116, 218). Subsequent end-trimming by exonucleases removes some of the terminal 
uridines, resulting in a population of RNAs slightly shorter than the initial transcription 
products; some of these no longer possess La binding sites (218). Neither the identity of 
the exonuclease nor its subcellular location is known. Ro travels to the nucleus prior to 
Ro RNP assembly, and binds the bulged Y RNA stem region (75, 187). Ro and La can 
bind a single Y RNA simultaneously (164).  Although La has been observed to shuttle 
between the nucleus and cytoplasm (55), La binding retards nuclear export of Y RNAs 
(77, 188). Thus, Y RNA 3' end shortening and elimination of the La binding site may 
occur prior to nuclear export (80, 175).  In unstressed wild type cells, most Y RNAs exist 
in the cytoplasm in a shorter, matured form, in an RNP complex containing Ro but not La 
(shorter mY1 RNAs lack the 3’ La binding site (Fig. 2-3A) and (116, 218)).  
 To address whether or not mY RNA encapsidation into MLV represented 
diversion of the RNAs from a specific stage in their maturation pathway, RNAs from 
wild type and Ro60-/- cells were first analzyed for signatures of Y RNA processing 
intermediates. Consistent with the Y RNAs in the knockout MEFs representing newly 
synthesized RNAs, the residual Y RNAs in Ro60-/- cells migrated slightly slower than 
the majority of the Y RNAs in wild-type cells, and thus exhibited the pattern observed for 
nascent La-bound Y RNAs (Fig. 2-3A and (24)). 
Next, the lengths of Y RNA processing intermediates in cells and virions were 
examined by high resolution denaturing acrylamide gels (Fig. 2-4A). These results 
confirmed that the spectrum of mY RNAs in knockout cells was longer than that in wild 
type cells.  The short length of mY RNAs in virions from wild type cells suggested that 
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La binding was not necessary for mY RNA packaging. However, the encapsidated RNAs 
from knockout cells were longer than those from wild type cells.  In both cell types, the 
RNA length distribution in virus was found to resemble that in the producer cells (Fig. 2-
4A), suggesting that packaging did not require mature 3’ end formation.  
To further address possible packaging of specific Y RNA subsets, high resolution 
gels were used to examine mY1 processing species distribution in cytoplasmic and 
nuclear fractions (Fig. 2-4B). Under the fractionation conditions used, the spectra of 
RNAs in knock-out cells’ cytoplasmic and nuclear fractions were indistinguishable (Fig. 
2-4B lanes 5 and 6). A subtle but reproducible slight bias toward more completely 
processed products was observed both in wild type cells’ cytoplasmic fractions (Fig. 2-
4B lane 3) and in virions (Fig. 2-4A lane 6), compared to these cells’ nuclear RNA 




Figure 2-4. mY1 RNA processing intermediates in cell and virus samples. (A) 
Northern blot of RNA from total cell and viral samples from wild type Ro60 +/+ MEFs 
and knockout Ro60 -/- MEFs, separated on 8% acrylamide, 8M urea sequencing gel and 
probed for mY1. Note that whereas lanes 1 and 2 contain equivalent samples, 20 times as 
much -/- cell sample was loaded in lane 3 as +/+ cell sample in lane 1 to facilitate 
qualitative comparison; lane 4 and lane 5 are RNA samples from supernatants of 
uninfected cells – the same volume of cell-free media as was used in lane 6; and virus 
samples (lane 6 and lane 7) were normalized to 7SL. (B) Northern blot of RNA from total, 
nuclear, and cytoplasmic fractions from wild type Ro60 +/+ MEFs and knockout Ro60 -/- 




 Retroviruses like MLV encapsidate distinct subsets of cellular non-coding RNAs 
(13, 149). Data here demonstrated that mY1 and mY3 RNA were recruited into budding 
MLV at four to five copies apiece from wild type MEFs and about 2 copies apiece from 
Ro60 knockout cells.  Although most mY RNA in cells resides in Ro RNPs, these RNAs 
were recruited into MLV without their cognate RNP protein, Ro60.  
 Similar observations of host protein-independent packaging of RNP RNA have 
been made for the SRP RNA, 7SL, which is packaged without the 54-kd SRP protein in 
both MLV and HIV-1 ((91, 150) and unpublished). Because of its essential role in signal 
recognition particles, direct knock-down of 7SL RNA is not readily achievable ((6) and 
unpublished).  Facilitating our analysis of MLV mY RNA packaging, viable Ro60 
knockout mice have been generated. Their cells lack Ro RNPs and display vastly reduced 
levels of mY RNAs (221). 
 We therefore used Ro60 -/- cells to examine the intersection of mY RNA 
biogenesis with MLV replication.  The normal spread of MLV in Ro60 -/- embryonic 
fibroblasts demonstrated that the Ro60 protein is not necessary for virus replication. 
Because mY1 and mY3 are highly labile in the absence of Ro60, knockout of Ro60 leads 
to a 30-fold reduction in these RNAs (221). Strikingly, this intracellular reduction was 
not accompanied by a proportional reduction in mY RNA packaging. Instead, mY1 and 
mY3 were so highly enriched that MLV’s selectivity for mY RNAs, from among all 




MLV’s high level of selectivity for mY RNAs led to our model in which Ro RNP 
and MLV assembly pathways intersect at an early step in Ro RNP biogenesis (Fig. 2-5). 
In this model for the encapsidation of mY RNAs without Ro60, the pathways of mY 
RNA biogenesis and MLV assembly intersect, and a virion-specifying factor diverts 
Ro60-free mY RNAs away from host cell RNA degradation machinery toward assembly 
sites on the plasma membrane (Fig. 2-5).    
 The similar Y RNA packaging observed in virions produced by cells with either 
high or very low intracellular Y RNA levels suggests that these RNAs are not recruited 
from RoRNPs, but from a separate intracellular pool of Ro60-free RNAs.  Towards 
localizing this intracellular pool, cell fractionation suggested MLV recruitment from an 
early pool of nascent mY RNAs. Consistent with the role of Ro60 in stabilizing mY 
RNAs (23, 101, 221), as well as the likely importance of Ro60 binding to Y RNA nuclear 
export (188), cytoplasmic pools of mY RNAs decreased more than the residual pool of 
nuclear mY RNAs in Ro60 knockout cells. Because this redistribution did not result in a 
corresponding decrease in Y RNA recruitment by MLV, it suggests that recruitment 
occurs at an unaffected, and possibly earlier, step in Y RNA biogenesis. 
 Precisely where this occurs was not resolved by monitoring 3’ end modifications 
that accompany Y RNA maturation. In virus from wild type cells, encapsidated RNAs 
resembled the biased pattern of Y RNAs in the cytoplasm.  However, encapsidated RNAs 
from Ro60 knockouts resembled more nascent RNAs.  The Y RNAs in knockout cells 
resembled longer nascent transcripts which have not undergone 3’ end maturation.  Thus, 
rather than indicating a cytoplasmic point of recruitment, these data suggest that 
recruitment into particles is independent of 3’ end maturation. 
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 Assuming that mY RNAs are recruited at the same step of their biosynthesis in 
both cell types, these results suggest that recruitment for packaging occurs before 3’ end 
maturation is completed but does not preclude subsequent 3’ end maturation. Because 
both La and Ro recognize and act on RNA motifs in the Y RNA stem and 3’ tail region, 
while other factors such as nucleolin and hnRNP I are known to interact with some Y 
RNAs via the internal loop (51, 56, 75), these findings may indicate that recruitment of Y 
RNAs occurs via interactions with the loop region that prevent degradation of Ro-
deficient RNAs but do not preclude 3’ end maturation (Fig. 2-5). Speculatively, the 
slower migration of residual Y RNAs in knockout cells may be suggestive of a role for 
Ro60 in exposing Y RNA 3’ ends for completing their exonucleolytic processing by an as 
yet unknown mechanism. 
 Because they are recruited early, one possibility is that mY RNAs may be selected 
for encapsidation into MLV from near their site of transcription in the nucleus (Fig. 2-5). 
The possibility of nuclear recruitment is plausible, considering that known pools of 
protein-free Y RNAs localize to perinucleolar sites of early RNP assembly (119). 
Although assembly of MLV, as for all retroviruses classically described as type C, is first 
visualized at the plasma membrane (57), the notion that retroviral late replication phases 
may include a nuclear step is not unprecedented. A portion of avian sarcoma virus Gag 
molecules transit through the nucleus prior to assembly (176-178). Although one study 
reported that 18% of MLV infected cell-associated Gag immunoprecipitated from nuclear 
fractions, it remains controversial whether or not retroviruses other than ASV share this 
step (137).  
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 The recruitment of mY RNAs at a nuclear subassembly step may involve MLV 
gRNA. The notion that MLV gRNAs transit directly from the nucleus to sites of 
assembly is supported by the propensity of sibling MLV gRNAs, but not those of HIV-1, 
to self-associate for packaging (53).  When sibling gRNAs are expressed from a single 
nuclear locus or proximal integration sites, they associate randomly (54, 92, 166).  The 
impact of nuclear distance on gRNA dimer partner selection argues for an early 
association of gRNA siblings and an early formation of a subviral RNP destined for 
encapsidation at the plasma membrane. If mY RNAs are recruited in the nucleus, they 
may join this hypothetical subviral RNP and accompany it to the plasma membrane, with 
the possibility that mY RNA binding may modulate the RNP’s intracellular trafficking, 
as it does for Ro RNPs (Fig. 2-5) (186).  
These findings of highly specific recruitment and enrichment of host RNP RNAs 
into MLV particles, even when the particles are produced by cells in which the RNAs are 
barely detectable, adds to growing evidence that the pathway of retroviral assembly—
from nuclear provirus to plasma membrane released virion—may be less linear than 
previously believed (199). Whether the apparent intersection of host and viral RNP 
biogenesis pathways is a fortuitous convergence, represents a viral evolved reliance on 
host RNP biosynthetic machinery, or is indicative of an abortive attempt of the host RNA 
quality control circuitry to thwart viral attack is not clear. The comparable packaging of 
similar subsets of noncoding RNAs in several different retroviral species does not 
immediately differentiate between these possibilities (6, 91, 149, 204), although the 
argument for chance interactions may be weakened if some retroviruses include a nuclear 
preassembly step while others do not (43, 53). Accumulating evidence suggests that some 
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viruses co-opt protein quality control machinery to aid their replication (217): the work 
here adds to evidence for a similar intersection between retrovirus assembly and cellular 





Figure 2-5. Ro RNP biogenesis and late stages of MLV replication.  A speculative 
model for their intersection based on observations reported here and Ro RNP assembly 
properties, as described in the text. The oval represents the nucleus; the light gray box 






Specific repression of Moloney murine leukemia virus transcription supports the 
early bisection in viral unspliced RNA into mRNA and genome fates. 
 
Abstract 
 Unspliced retroviral RNAs function as genomes (gRNA) for packaging and 
mRNAs for translation.  Where and when gRNAs initially form dimer partner 
associations or are recruited for packaging likely differs among retroviruses.  For 
Moloney murine leukemia virus (MLV), previous findings with actinomycin D treated 
cells suggest that MLV unspliced RNAs sort into non-equilibrating pools of gRNAs and 
mRNAs.  Prior work from our lab and others on the randomness of gRNA dimer 
populations suggests that unlike HIV-1, MLV gRNA dimer partner selection may occur 
before RNAs exit the nucleus, suggesting that the bisection in gRNA and mRNA fates 
occurs before nuclear egress.  Here, tetracycline-regulated MLV transcription was used to 
repress MLV transcription in a more targeted fashion in order to re-address the two pool 
phenotype of MLV unspliced RNA.  Specific repression of MLV transcription led to a 
more rapid decline in gRNA packaging than virion production, which is consistent with 
earlier findings where transcription was inhibited globally with actinomycin D.  
Additionally, packaged gRNA dimer populations were analyzed at various time points 
after both specific and general transcription inhibition.  The results indicated that 
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transcription inhibition led to increased randomness in gRNA dimer partner associations 
and a parallel increase in recombination under both conditions, albeit with residual biases 
consistent with an ongoing partitioning between mRNAs and genomes.   These data 
suggest that the small population of heterodimers in MLV co-expression studies arise 
from a subset of gRNAs that escape early dimer partner associations and form dimer 
associations more randomly later.  Together, our observations suggest that MLV 
unspliced RNA fates are determined early in the host cell nucleus and support the early 
separation of MLV unspliced RNAs into two largely non-equilibrating pools.   




 Retroviruses use unspliced RNA as either genome (gRNA) or mRNA.  In order to 
package gRNA into viral particles, retroviruses must sort gRNA away from viral mRNA.  
All retroviral gRNAs are packaged in pairs, and this shared property may provide a 
mechanism for the separation and recruitment of paired gRNAs from the pool of unpaired 
viral mRNAs. Where gRNAs form pairs and diverge from viral mRNAs likely varies 
among retroviruses.  
 Where are retroviral unspliced RNAs initially recruited into assembling virions?  
Different packaging mechanisms contribute to diversity in the potential subcellular 
locations where RNAs might first encounter packaging machinery.  The cis-preference 
for Line-1 genomic RNA incorporation into ribonucleoprotein (RNP) retrotransposition 
intermediates supports a cytoplasmic site of initial recruitment (99, 214).  Similarly, the 
recruitment of human immunodeficiency virus type 2 (HIV-2) RNAs from the pool of 
translating viral mRNAs indicates a cytoplasmic point of initial recruitment (76, 88).  
Studies using actinomycin D (ActD) as a general transcription inhibitor suggest that HIV-
1 and HIV-2 gRNAs are recruited from the same pool of RNAs that function as mRNA 
(43).  This suggests that, like HIV-2, the initial point of recruitment for HIV-1 gRNAs is 
in the host cell cytoplasm.  Unlike HIV-2 gRNAs, HIV-1 gRNAs can be packaged in 
trans, which suggests a potential cytoplasmic recruitment from a location separate from 
translating viral mRNA (17, 88, 139). 
 For murine leukemia virus (MLV), studies using ActD have suggested that the 
MLV unspliced RNA that functions as mRNA is unavailable for packaging (107, 108).  
This implies packaging occurs in trans and suggests that MLV unspliced RNA segregates 
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into separate nonequilibrating pools of mRNA and gRNA (108).  By quantifying 
packaged MLV gRNA and intracellular viral RNA after ActD treatment, Messer et al. 
(122) showed that intracellular viral RNA had a half-life three to four times greater than 
packaged gRNA.  This suggests that MLV gRNAs move rapidly from the initial point of 
recruitment to sites of assembly.   
 Prior studies of gRNA dimer partner selection between two distinct co-expressed 
gRNAs have provided evidence that MLV gRNAs form pairs at or near sites of 
transcription and further suggest an early separation of gRNAs from unpaired viral 
mRNAs (53, 54). It was observed that MLV gRNAs expressed from separate nuclear loci 
preferentially self associate and therefore exhibit nonrandom dimerization (53).  In 
contrast, when distinct MLV gRNAs were expressed from a single locus or proximal 
nuclear loci, they dimerized randomly (54, 92, 166).   
 Flynn et al. (53) showed that, unlike MLV, co-expressed HIV-1 gRNAs dimerize 
randomly, which is consistent with more recent observations of the random association of 
fluorophore-tagged HIV-1 gRNAs tagged in a single virion visualization assay (22).  
Through manipulation of palindromic sequences within the dimer initiating signal (DIS) 
of HIV-1 gRNAs, Moore et al. (127) provided evidence that gRNA dimerization precedes 
packaging in HIV-1.  Recently, a cell fusion assay was used to compare the 
recombination of HIV-1 gRNAs produced from separate nuclei to the rate of 
recombination of HIV-1 gRNAs produced from the same nucleus (128).  The 
observations that recombination rates were similar between the two conditions and that 
nuclei remained separate and intact further suggest that HIV-1 gRNAs form dimers 
randomly in the host cell cytoplasm (128).  
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 This difference in RNA trafficking between MLV and HIV-1 also accounts for 
observed differences in recombination rates between the two in single cycle 
recombination assays (52, 151, 228).  The more random dimerization of HIV-1 leads to 
greater genetic marker cosegregation and recombination than MLV, which displays 
relatively low rates of recombination due to preferential packaging of homodimers. The 
nonrandom dimerization of MLV gRNAs and its comparatively low level of 
recombination are consistent with the ActD inhibitor studies.  Together, these 
observations suggest that MLV gRNAs form pairs and separate from viral mRNA early 
in their biogenesis. 
 Although general transcription inhibition with ActD has suggested a bifurcation in 
MLV unspliced RNA fates, it remains a strong possibility that the two nonequilibrating 
pools of MLV RNA may arise from indirect consequences of this mode of general 
transcription inhibition.  Some indirect or off target effects of ActD treatment include 
disruptions to translation initiation (190), disruptions to cytoplasmic mRNA processing 
body (P body) stability (29, 212) (reviewed in (49)), and disruptions to nuclear-to-
cytoplasmic shuttling of host cell proteins (86, 87, 104, 143).  These disruptions could 
lead to changes in MLV unspliced RNA trafficking patterns, or to disruptions of cellular 
physiology that might sequester viral or cellular factors required for gRNA packaging.   
 Here, we sought to address whether or not the two-pool hypothesis could 
withstand more stringent testing by using targeted repression of MLV transcription to 
eliminate indirect/off target effects of general transcription inhibition.  Notably, we 
observed a bifurcation in the fates of MLV unspliced RNA that was similar to the 
bifurcation which results from ActD treatment when we inhibited MLV transcription 
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specifically.  Testing the prediction that this separation in gRNA from viral mRNA is 
linked to early dimer partner selection, we also demonstrate here that both the 
randomness of gRNA dimerization and the levels of recombination increased when early 
events were disrupted by transcription inhibition.  Lastly, we show a long half-life for 
MLV unspliced RNA in nuclear fractions which paralleled MLV unspliced RNA 
decreases in the host cell cytoplasm.  Together, these data support an early separation of 
MLV gRNA from viral mRNA from within a long-lived pool of unspliced RNA in the 








Materials and Methods 
Cells.  293T cells (human embryonic kidney cells expressing SV40 T antigen) 
were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) 
supplemented with 10% fetal calf serum (Gemini).  NIH 3T3 cells, 3T3 cells chronically 
infected with MLV, and D17/pJET cells (144) (canine osteosarcoma cells expressing 
murine ecotropic receptor) were maintained in DMEM (Invitrogen) supplemented with 
10% bovine serum (Invitrogen).   
A tetracycline (Tet) (Sigma)-inducible MLV cell line was constructed by site-
specific recombination of MLV under control of TetO2 operator sequences into Flp-In™ 
T-REx™ -293 cells (derived from human embryonic kidney cells (73)) (Invitrogen).  
This was done by co-transfection of pEG483-4 (described below) with pOG44 (which 
expresses the Flp recombinase under the control of the human CMV promoter) into Flp-
In™ T-REx™ -293 cells.  Flp-In™ T-REx™ -293 cells contain two stable, independently 
integrated plasmids pFRT/lacZeo and pcDNA6/TR.  pFRT/lacZeo introduced a single 
Flp Recombination Target site (FRT) site into the 293 cell genome, and it stably 
expresses the lacZ-Zeocin™ fusion gene by the SV40 early promoter.  pcDNA6/TR 
constitutively expresses the TetR repressor from the cytomegalovirus (CMV) immediate-
early enhancer/promoter.  Flp-In™ T-REx™ -293 cells and Tet-inducible MLV cells 
were grown in DMEM supplemented with 10% fetal calf serum (Gemini). 
Virus – tetracycline-regulated repression of MLV transcription.   For our 
study of the selective repression of MLV transcription, virus was harvested from cells 
maintained under induction with 1 μg/ml tetracycline (Tet) (Sigma) and from cells where 
MLV transcription was shut off by removal of Tet.  After ~96 hours of induction and 72 
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hours of serum deprivation, virus was harvested at 2 hour time intervals from media 
supernatants of cells either maintained under induction in the presence of Tet or from 
media of cells where MLV transcription was repressed by removal of Tet.   
Virus – general transcription inhibition with ActD or DRB.  To recapitulate 
previously reported observations of the MLV unspliced RNA response to actinomycin D, 
virus was harvested from chronically infected 3T3 cells at two hour time intervals before 
and after treatment with 1 ug/ml actinomycin D (Sigma).   
For two vector dimerization and recombination experiments, virus was produced 
by transient transfection of plasmids into 293T cells by calcium phosphate precipitation 
(225), and virus-containing media was harvested at indicated time points pre or post 
treatment of transfected 293T cells with 1 μg/mL actinomycin D (Sigma) or 100 μM 5,6-
dichlorobenzimidazole riboside (DRB) (Sigma).  All virus was filtered through a 0.2-μM 
MCE syringe filter (Fisher Scientific), and stored at -70ºC prior to use.  
Plasmids.  pMLV is an infectious MLV proviral clone also known as pNCA (28).  
pMΨPuro is an MLV-based vector containing cis-acting sequences for RNA dimerization 
and packaging as well as a puromycin resistance gene driven by a simian virus 40 (SV40) 
early promoter (pAM86-5) (98).  The helper plasmid pNGVL-3’-gagpol, which expresses 
MoMuLV Gag and Gag-Pol from a 5’ leader-deleted transcript driven by the CMV 
promoter, has been described previously (225).  The MLV recombination vectors MLV 
Lac (also called pNR1755-1) and MLV L^cPuro (also called pNR1727-1) have been 
described previously (151).  Briefly, MLV Lac contains lacZ driven by the MLV long 
terminal repeat (LTR).  MLV L^cPuro was derived from the same plasmid as MLV Lac, 
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but it contains a 117-bp deletion between the EcoRV and SspI sites of lacZ and a SV40 
early promoter followed by a puromycin resistance gene.   
Riboprobes were templated by pBluescript II SK or KS (+/-) (Stratagene)-derived 
plasmids.  pAO993-11 is an MLV 5’ UTR-7SL chimeric riboprobe template that has 
been described previously and was used here to quantify gRNA/RT activity and 
gRNA/7SL (149).  pD1040-2 is a gag riboprobe template that has been described 
previously and was used here to detect MLV RNA in Tet-inducible cells and 
MLV/MΨPuro RNAs in RNA captures (53, 183).  pSRK38-7 is an HIV-1 pol-7SL 
chimeric riboprobe template that has been described previously and used here as a probe 
for 7SL RNA in Tet-inducible cells (150).  pEG623-1 is a β-actin mRNA riboprobe 
template generated by PCR of mouse cDNA with oligos EG96 5’-
CGCCGACTAGTAGCCATGTACGTAGCCATCC-3’ and EG97 5’-
CGAGTGCGGCCGCCTCTCAGCTGTGGTGGTGAA-3’ that was blunt end cloned into 
the EcoRV site of pBluescript II SK (+/-). 
For generation of a MLV inducible cell line, MLV from pNCA was sub-cloned 
into pcDNA5/FRT/TO© (Invitrogen).  For Tet-regulated expression of MLV, overlap 
extension PCR was used to fuse the MLV transcription start site in R with the hybrid 
hCMV/TetO2 promoter from pcDNA5/FRT/TO©.  The internal oligos for this were:  
EG82 5’-GCTCGTTTAGTGAACCGCGCCAGTCCTCCGATTG-3’ and EG83 5’-
CAATCGGAGGACTGGCGCGGTTCACTAAACGAGC-3’.  The resulting plasmid was 
pEG483-4. 
Exogenous RT assay.  Media supernatants were harvested, filtered through 0.2-
μM MCE syringe filters (Fisher Scientific) and stored at -70 ºC.  RT assays were based 
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on a protocol by (70) as described previously (203) to measure the amount of RT activity 
in media supernatants with an exogenous template.  
Dimeric viral RNA extraction.  Previously reported dimeric viral RNA 
extraction methods, which isolate MLV gRNAs without disrupting their non-covalent 
dimer associations (53),  were modified by using 30 ml of virus-containing medium over 
2 ml of 20% sucrose in phosphate-buffered saline and centrifuging at 113,000 × g for 2 h 
at 4ºC.   
RPAs.  To quantify gRNA packaging in virus from ActD treated cells and 
gRNA/7SL in virus from Tet-inducible cells, pAO993-11 was linearized with Hind III 
and transcribed using T3 RNA polymerase (Promega) and [α-32]CTP to create a 436-nt 
transcript which protected 201 nt of MLV RNA and 99 nt of 7SL RNA.  To quantify 7SL 
in Tet-inducible MLV cells, pSRK38-7 was linearized with SalI and transcribed with T7 
RNA polymerase (Promega) to generate a 344-nt transcript that protects 101 nt of 7SL 
RNA.  To quantify MLV unspliced RNA in Tet-inducible MLV cells and to detect 
MLV/MΨPuro in RNA captures, pD1040-2 was linearized with EcoRI and transcribed 
using T3 RNA polymerase (Promega) to create a 400-nt transcript which protected 330 nt 
of MLV RNA and 289 nt of MΨPuro RNA.  To quantify β-actin mRNA in nuclear and 
cytoplasmic fractions, pEG623-1 was linearized with EcoRI and transcribed using T7 
RNA polymerase (Promega) to create a 311-nt transcript which protects 228 nt of exon 4 
of mouse β-actin mRNA. 
Previously described RNase protection assay (RPA) approaches using RNase T1 
(Ambion) and RNase A (Roche) (53) were modified by extending hybridization times to 
16 h (Applied Biosystems).  Bands were quantified by PhosphorImager for detection and 
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ImageQuant TL for analysis.  Bands were adjusted for the number of radiolabeled Cs 
incorporated. 
Cell fractionation.  NIH 3T3 cells and chronically infected 3T3 cells were 
fractionated using a modification of the digitonin (Sigma) procedure of Siomi et al. (191) 
as previously described (65) which selectively permeabilizes the plasma membrane.  
Northern blots. Northern blots were used to visualize RNAs for fractionation 
controls.  Hybridization probes were oligonucleotides complementary to the RNAs of 
interest, 5’ end labeled using γ-32P ATP (Perkin-Elmer) and T4 polynucleotide kinase 
(NEB). Labeled oligonucleotides were separated from unincorporated nucleotides on G-
25 sephadex columns (Roche). Oligonucleotides included 5’-
GGATAAACCTCGCCCTGGGAAAACCACCTTCGTGATCATG-3’ for U1 and 5’-
GAGTCCCACGCTCTACCAACTGAGCTAGCTG-3’ for tRNALys1. Viral and cellular 
RNAs were separated by 8% polyacrylamide-8M urea gel electrophoresis in 1X TBE. 
RNAs were subsequently transferred by electroblotting to Zeta-probe GT Nylon 
membranes (Bio-Rad) in 0.5X TBE. Membranes were air dried, UV crosslinked 
(Stratalinker; Stratagene), and prehybridized at 52 ºC in 6X SSC-5X Denhardt’s solution-
0.5% SDS-0.025M sodium phosphate-625µg/ml denatured salmon sperm DNA. 
Oligonucleotide probes were denatured at 85 ºC for 5 minutes before adding to the 
membranes, and hybridization was at 52 ºC.  Blots were washed first in 2X SSC-0.1% 
SDS at 50 ºC, and then in 0.33X SSC-0.1% SDS at 50 ºC. Damp blots were wrapped in 
plastic wrap and exposed to phosphorimager screens and/or film. For re-probing, blots 




 Infection and functional assay for LacZ activity.  D17/pJET cells in 6-cm-
diameter dishes were infected for 1 h in the presence of 5 μg of hexadimethrine bromide 
(Polybrene; Sigma) per ml at low multiplicities of infection (<0.01).  After 24 h, cells 
were transferred to 10-cm-diameter dishes using 0.5 ml of 0.05% trypsin (Invitrogen).  48 
h after infection, cells were placed in selection media containing 1 μg/ml puromycin 
(Sigma).  Selection, cell fixation, and 5-bromo-4-chloro-β-D-galactopyranoside (X-Gal) 
(Sigma) staining were performed as previously reported (158). 
 RNA capture assay.  The RNA capture assay protocol, a biotinylated-oligo 
mediated method for the capture/pull down of dimeric RNA, was adapted from that 
previously described (53).  The modifications included increasing the number of washes 
to 7 and increasing the stringency of the washes by lowering the salt concentration of the 
wash buffer to 0.33× SSC (50 mM NaCl) and heating to 50ºC. 
 Tet induction and shut-off.  Sub-confluent 10-cm diameter dishes of Tet-
inducible MLV cells (~2×106 cells/10-cm diameter dish) were split 1:8 (~2.5×105 
cells/10-cm diameter dish) onto new 10-cm diameter dishes with 0.05% Trypsin-EDTA 
(Invitrogen).  The cells were placed in fresh DMEM supplemented with 10% fetal calf 
serum (Gemini) either with or without 1 μg/ml Tet (Sigma).  After 24 hours, the serum-
containing media was replaced with serum-free media to obtain a more synchronous cell 
population and lessen the experimental variation in our study, and cells were maintained 
with or without Tet.  Serum-free media with and without Tet was replaced every 24 hours 
for the next 48 hours.  After 48 hours, the serum-free media with and without Tet was 
replaced every six hours until approximately 72 hours.  At 72 hours, cells were placed 
back in DMEM supplemented with 10% fetal calf serum (Gemini).  At this same time 
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point, Tet was removed from a subset of cells to shut off MLV transcription.  MLV 
expression was monitored by media RT activity of cells that were under continual 
induction, cells that were never induced, and cells that were shut off following induction.  
RT levels and virion RNA levels were monitored every 2 hours from the time of shut off 




Consistent with previous studies, general transcription inhibition results in a more 
rapid decline in MLV gRNA packaging than virion production. 
 Previous studies of MLV unspliced RNA sorting used general transcription 
inhibition to reveal a separation of MLV gRNA from viral mRNA (107).  For comparison 
with specific inhibition of MLV transcription, this earlier experiment was reproduced 
here by actinomycin D (ActD) treatment of chronically infected mouse fibroblasts, 
measuring RT activities and packaged gRNA levels after ActD treatment (Fig. 3-1A and 
1B).  RT activities, which provided an indication of virion production and an indirect 
measure of intracellular viral mRNA levels, declined gradually over time to around 40% 
by 10 hours post ActD treatment (Fig. 3-1A).  When viral supernatants were normalized 
to RT activity, packaged gRNA levels declined rapidly to less than 20% of initial levels 
by 4 hours post ActD treatment, and gRNA levels were barely detectable by 10 hours 
post ActD treatment (Fig. 3-1B).  These data recapitulate the earlier data, which suggests 
a two-pool phenotype of MLV unspliced RNA and significant difference in the half lives 
of packageable gRNA versus virion-producing intracellular viral mRNA.   
Specific repression of MLV transcription results in a more rapid decline in gRNA 
packaging than virion production.   
 In order to determine if the functional separation of MLV unspliced RNA fates 
was a direct or indirect result of treatment with ActD, a more targeted inhibition of MLV 
transcription was used to minimize global disruptions to cell physiology and RNA 
trafficking.  In order to specifically shut off MLV transcription, a full length MLV 
provirus was placed under control of tetracycline (Tet) by replacing the 5’ U3 region with 
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a CMV promoter regulated by Tet operator sequences.  This construct was site-
specifically recombined into 293 cells that constitutively express the TetR repressor.  In 
this system, transcription of MLV unspliced RNA is turned on in the presence of Tet and 
turned off in the absence of Tet, or upon Tet removal.   
 The rate of MLV shut off in this system was first tested by repressing MLV 
transcription after a period of induction and monitoring virion production by RT activity 
in media supernatants(Fig. 3-1C).  The rate of decline in virion production was 
determined for cells deprived of Tet (after a period of induction) and compared to levels 
for cells under constant induction (Fig. 3-1C).  The rate of decline in RT activity upon 
MLV transcription shut was comparable to the rate of decline in RT activity post ActD 
treatment. Both methods of MLV transcriptional shut off reduced RT to ~40% of 
uninhibited levels by 10 hours (Fig. 3-1A and 1C).  Therefore, specific shut off of MLV 
transcription produces a rate of decline in virion production which is consistent with the 
rate observed with ActD-mediated transcription inhibition. 
 Upon specific shut off of MLV transcription, changes in packaged gRNA levels 
were determined through direct comparison with copackaged 7SL RNA, a host RNA 
packaged by MLV at levels proportionate to virion proteins (149) (Fig. 3-1D).  An RNase 
protection assay (RPA) was used to determine the ratio of gRNA to 7SL in virion RNA 
from cells under constant induction to that from cells where MLV transcription was 
repressed (Fig. 3-1D).  Quantification of gRNA to 7SL ratios over time revealed a two-
fold decline in gRNA/7SL in virus from cells in which MLV transcription had been 
switched off (Fig. 3-1D).  The gRNA to 7SL ratios appeared to level off between 6 to 10 




Figure 3-1. RT activities and packaged gRNA levels post transcription inhibition. (A) 
RT activities of media samples were quantified before and after the addition of 1 μg/ml 
ActD to chronically-infected NIH-3T3 fibroblasts.  For all 2 hour time points, data are 
represented as values relative to RT activities of media before ActD, which was set at 
100%.  (B) gRNA packaging from virus harvested before and after ActD treatment was 
measured by RPA and normalized to RT activity.  The gRNA packaging levels per RT 
before ActD were set to 100% and subsequent time points are plotted as a percentage of 
this value, T0.  (C) RT activities of media supernatants were quantified for 2 hour time 
points post specific repression of MLV by Tet removal from cells previously under 
induction.  Data are expressed as values relative to media supernatants harvested at 
corresponding time points from cells kept under induction.  Maximum RT activities were 
achieved 2 hours after Tet shut off and serum replacement, and this average value was set 
to 100%.  (D) gRNA packaging was quantified by RPA of gRNA per 7SL from virus 
harvested from 2 hour time points after specific repression of MLV transcription.  Large 
error bar at 4 hours post shut off may indicate no change at this time point, but the 
subsequent time points reveal a ~2-fold drop in gRNA/7SL.  Levels are presented as a 
percentage of the values obtained for virus harvested from cells kept under induction.  
Maximum levels again achieved 2 hours after specific repression, and this average value 
was set to 100%.  Data from all the experiments presented here represent the average of 
two independent experiments. 
 70
 
demonstrating an apparent shorter half-life of gRNA than viral mRNA, these data are 
consistent with the separation in MLV unspliced RNA fates revealed by ActD treatment.  
However, the observed decline in gRNA packaging was more modest than seen after 
ActD treatment.  
Transcription inhibition leads to an increase in the randomness of gRNA dimer 
partner selection.   
 Previous studies suggest that the majority of MLV gRNAs likely form dimer 
partner associations at or near sites of transcription (53, 54).  This suggests that the 
bisection in MLV unspliced RNA fate occurs early in the biogenesis of the RNA.  
Because previous evidence suggests that gRNA packaging persists 8-10 hours post 
transcription inhibition with ActD (43, 122), albeit at low levels, it was possible to 
disrupt early events with transcription inhibition and test outcomes on the randomness of 
dimer partner associations over time after transcription ceased.  Therefore, the 
randomness of dimer partner selection was measured by an RNA capture assay before 
and after 10-12 hours of ActD treatment (Fig 3-2A and 2B).  Untreated samples 
displayed nonrandom elution ratios that were consistent with previous findings of MLV 
gRNA preferential self-associations (Fig. 3B) and (53).  In contrast, an approximately a 
two-fold increase in the level of randomness was observed at 10-12 hours after ActD 
treatment (Fig. 3-2A and 2B).   When the elution ratio expected from randomness is set to 
one, a change in elution ratio from 4.9 pre-ActD treatment to 2.5 at 10-12 h post-ActD 
treatment was observed.  This suggests that a small portion of coexpressed MLV gRNAs 




Figure 3-2. Randomness of MLV gRNA dimer partner associations before and after 
transcription inhibition.  (A) RPA of viral RNA from an RNA capture assay of 
untreated samples, T0, and samples from 10 to 12 hours after the addition of 1 μg/ml 
ActD, T10-12.  Lane designations indicate the following:  i, input; ft, flow through; fw, 
final wash; e, elution; P, undigested probe; M, RNA marker; and C, no RNA digested 
probe control.  Using the Hardy-Weinberg equation (53), the ratio of MLV and MΨPuro 
gRNAs in input (i) lanes was used to calculate the ratio of the two gRNAs in the elution 
lanes expected from randomness.  The expected ratio was then compared to empirical 
elution (e) ratios.  (B) comparison of the elution ratios before and 10-12 hours after ActD 
treatment.  The expected elution ratio was set to 1.  Data represent the average of two 
independent RNA capture experiments.  (C) RPA of an RNA capture assay of RNA 
extracted from virions before and 10 to 12 hours after the addition of 100 μm DRB.  (D) 
comparison of the elution ratios before and 10-12 hours after DRB treatment.  The 
elution ratio expected from randomness was set to one.  Data represent the quantification 
of the RPA shown in (C). 
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randomly later.  When the nascent gRNA population is disrupted by transcription 
inhibition, the remaining gRNAs formed dimer partner associations more randomly. 
Increases in randomness of gRNA dimer partner selection are independent of the 
mode of transcription inhibition.   
 As another way to address if the randomness of gRNA dimerization seen at late 
time points post ActD was a direct or indirect effect of ActD treatment, the randomness 
of dimerization was measured before and after the use of an alternate transcription 
inhibitor, DRB. DRB specifically disrupts RNA polymerase II (Pol II) elongation by 
inhibiting phosphorylation of the carboxy terminal domain of the largest Pol II subunit by 
positive transcription elongation factor b (p-TEFb), a cyclin dependent kinase (211, 223).  
DRB also activates the DRB-sensitivity inducing factor (DSIF) (210, 223), which causes 
Pol II pausing in conjunction with negative elongation factor (NELF) (136, 222).   
 After 10 -12 hours of treatment with 100 μM DRB, a two-fold increase in the 
level of encapsidated gRNA randomness was observed (Fig. 3-2C and 2D).   When the 
elution ratio expected from random dimer partner associations is set to one, a change 
from measured elution ratios of 4.6 prior to DRB treatment to 2.4 at 10-12 h post DRB 
treatment was observed.  This result reconfirmed that the increase in the randomness of 
dimerization that is seen at late time points post transcription inhibition is independent of 
the mode of transcription inhibition.  
A post transcription inhibition increase in recombination parallels the increase in 
randomness of dimer partner selection.   
 The tendency of MLV gRNAs to preferentially self associate can fully account for 
the low rate of MLV recombination relative to that of HIV-1, as measured in two vector 
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recombination assays (52, 228).   Recombination, therefore, provides a sensitive, albeit 
indirect, measure of the randomness of gRNA dimer associations.  To test if disruptions 
to early events which lead to increased randomness in dimer partner associations also 
lead to increases in recombination, MLV gRNA recombination was measured from virus 
harvested at various time points post transcription inhibition (Fig. 3-3A).  In the two 
vector recombination assay used here, recombination between co-packaged gRNAs is 
monitored using markers for puromycin resistance and β-galactosidase activity (Fig. 3-
3A).  Only when gRNA heterodimers are packaged is there a potential for the generation 
of a provirus that will contain both genetic markers (Fig. 3-3A).   
 Coupling this recombination assay with transcription inhibition provided a means 
of testing outcomes of disrupting nascent transcript associations on the frequency of 
gRNA heterodimer packaging.  Post transcription inhibition with ActD, a two log drop in 
titer was observed (Fig. 3-3B).  This two log drop was accompanied by a 3-fold increase 
in recombination at 10 hours after ActD treatment (Fig. 3-3C).  Thus, an increase in 
recombination paralleled the increase in the randomness of dimer partner associations 
seen above by RNA capture.   
 The general inhibition of transcription with ActD can alter RNA trafficking 
pathways, possibly contributing to the observed changes in the randomness of dimer 
partner associations and recombination.  Thus, to further test the notion that a portion of 
MLV gRNAs can escape early partner associations and form dimers after the completion 
of transcription, MLV transcription was specifically ablated by taking advantage of the 
transient nature of gene expression after plasmid DNA transfections.  Using the two 




Figure 3-3.  Recombination frequency between co-expressed MLV gRNAs post 
transcription inhibition.  (A) heterodimeric recombination in a two-vector single cycle 
assay.  The diagram illustrates recombinogenic template switching between co-packaged 
gRNAs in the reverse transcription of proviral DNA with a functional β-galactosidase 
gene and a puromycin resistance cassette.  (B) titer after ActD treatment.  Titer is 
displayed as puromycin resistant colony forming units (cfu) from pre-ActD treatment, 
hour 0, to 10 hours after ActD treatment.  (C) levels of recombination reported as the 
percent of blue colony frequency before and after ActD treatment.  Data represent the 
average of two independent experiments with at least 500 colonies counted per time point 
per experiment.  (D) levels of recombination four to five days after transfection compared 
to a 30-32 hour time window.  The 30-32 hour represents a time window where virion 
production was at or near peak levels, and the 96-120 hour time point corresponds to 
more than a two fold drop in virion production as measured by RT activity.  Data 
represent the average of two independent infections, with a minimum of 300 colonies 
counted per time point per infection. 
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after transfection: one window for active MLV gene expression and the other when MLV 
gene expression was likely shutting down.  To determine the appropriate time point post 
transfection, RT assays of media were first used to determine when virion production 
declined to a similar extent as was observed at 10 hours after ActD treatment.  Taking RT 
assays of media supernatant every 24 hours, a drop of RT activity to at or below 45% of 
maximum levels was observed 96 to 120 hours after transfection.  Therefore, the 
recombination rate observed with virus harvested at this time point was compared to an 
earlier time point, 30-32 hours post transfection, that represented a time of active 
transcription and high virion production.  The results indicated a four fold increase in the 
rate of recombination to a 2.8% blue colony frequency at the late time point post 
transfection (Fig. 3-3D).  This increase was equivalent to the increase observed at 10 
hours post ActD treatment (Fig. 3-3C) which suggests that the rise in recombination was 
a direct consequence of inhibiting MLV gene expression and not an indirect consequence 
of general transcription inhibition with ActD. 
Abundant nuclear MLV unspliced RNA exhibits a low rate of decay that is 
paralleled by MLV unspliced RNA in the cytoplasm.   
 The results above point to an early gRNA sorting event, and suggest that MLV 
gRNA is likely recruited to sites of assembly prior to nuclear export.  Dorman and Lever 
(43) showed that the cytoplasmic MLV unspliced RNA population has a very slow 
decline compared to encapsidated viral gRNA levels after transcription inhibition.  This 




 To measure the decline in the nuclear MLV unspliced RNA relative to 
cytoplasmic MLV unspliced RNA, chronically-infected cells were fractionated with 
digitonin over a 10 hour time window after ActD treatment.  Nuclear and cytoplasmic 
MLV unspliced RNA levels (Fig. 3-4A and 4B) were quantified by RPA and compared 
to total mouse β-actin mRNA levels (Fig. 3-4C and 4D).  A northern blot separately 
probed for nuclear U1 snRNA and cytoplasmic tRNALys1 served as a control for the 
fractionation (Fig. 3-4E and 4F).  At all time points, more than 90% of MLV gRNA co-
purified with the nuclear fraction (Fig. 3-4A and 4B).  In contrast, nuclear and 
cytoplasmic fractions contained near equal levels of mouse β-actin mRNA prior to ActD 
treatment (Fig. 3-4C and 4D); however, the levels of β-actin mRNA shifted away from 
the cytoplasm and became elevated, near 80% of total, in the nucleus after ActD 
treatment (Fig. 3-4C and 4D), possibly indicating that β-actin mRNA localization is 
disrupted by ActD.  Nuclear U1 levels, which varied by less than 24% throughout the 
time points tested, were used to normalize relative cell amounts and to determine an 
approximate rate of decay of nuclear MLV unspliced RNA.  Normalizing to U1, nuclear 
MLV unspliced RNA exhibited a half-life of approximately 11 hours.  Over the tested 
time course, the tRNALys1 control for the cytoplasmic fraction declined by more than 50%.  
However, the ratio of cytoplasmic to total MLV unspliced RNA varied by less than 2% 
over the same time course.  Thus, the decline in the levels of cytoplasmic viral RNA per 
volume paralleled the declines in the nucleus per volume which suggests that the half-life 




Figure 3-4. MLV unspliced RNA and total β-actin mRNA nuclear and cytoplasmic 
levels post ActD. (A) RPA of MLV unspliced RNA extracted from nuclear and 
cytoplasmic fractions of chronically infected NIH-3T3 cells before or after ActD 
treatment or from mock-infected NIH-3T3 cells.  Cells were fractionated with 0.01% 
(wt/vol) digitonin.  (B) Quantification of RPA from (A). (C) RPA of nuclear and 
cytoplasmic fractions from (A) for total mouse β-actin mRNA.  (D) Quantification of 
RPA from (C). (E) northern blot of nuclear and cytoplasmic fractions from (A) probed 
separately for nuclear U1 snRNA and cytoplasmic tRNALys1 for use as fractionation 




 Where and when retroviral gRNAs are initially recruited for virion inclusion 
affects the recombinogenic potential of the virus by influencing the make up of gRNA 
dimer populations.  Work performed here tested hypotheses with regards to the initial 
point of recruitment of MLV gRNAs. Upon specific Tet-repression of MLV transcription, 
a more rapid decline in gRNA packaging relative to virion production was observed.  
These observations are consistent with previous findings with ActD which suggested the 
bisection of MLV unspliced RNA into separate pools of gRNA and mRNA.  In order to 
test the hypothesis that this bisection in RNA fates occurs early in the biogenesis of the 
RNAs, the effect of transcription inhibition on gRNA dimer populations was analyzed for 
levels of randomness, using biochemical and genetic assays.  Transcription inhibition led 
to increases in gRNA dimer partner selection and recombination, to levels that were 
consistent with later gRNA pairings but belied a residual bias for partitioning between 
gRNA and mRNA fates.  Overall, these data are consistent with the initial recruitment of 
MLV gRNAs from host cell nuclei. 
 In combination, the more rapid decrease in gRNA packaging relative to virion 
production and the increases in the randomness of gRNA dimer partner associations and 
recombination led to our model in which the bisection of MLV unspliced RNAs takes 
place in the host cell nucleus (Fig. 3-5).  In this model, high local concentrations of 
nascent transcripts favor preferential self associations at or near sites of transcription(Fig. 
3-5).  This model, however, also suggests that a subset of gRNAs may escape early dimer 
partner associations and either diffuse or be actively relocated within the nucleus to areas 
de-enriched for self (Fig. 3-5).  Thus, this latter subset of gRNAs may form partner 
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associations more randomly (Fig. 3-5) and may contribute disproportionately to the small 
portion of heterozygous virions that are present in co-expression studies.  It may be 
possible that some dimer partner associations do not arise until the unspliced RNAs reach 
the cytoplasm, but genetic differences between HIV-1 and MLV, differences in the rates 
of recombination and in the randomness of dimer partner associations in co-expression 
studies, suggest that very few MLV gRNAs take this route.  Whether among the pool of 
nascent transcripts or the low level gRNA dimers that form later, nuclear dimer partner 
associations represent an initial point of recruitment and a likely branch point in the 
divergence of MLV unspliced RNA to separate fates of gRNA or mRNA. 
 In this model, nuclear dimer partner associations could function to switch the 
RNA into a fold that is subsequently recruited by MLV Gag to sites of assembly.  In the 
upcoming Chapter IV, the RNA switch hypothesis linking gRNA dimerization to 
packaging is discussed in more detail.  Briefly, in vitro evidence suggests that gRNA 
dimerization exposes high affinity NC binding sites within the MLV Ψ that function in 
gRNA packaging (36).  Our results suggest that MLV gRNA may form dimers in the host 
cell nucleus which would lead to exposure of high affinity NC binding sites.  Thus, 
binding of Gag to dimeric RNA in the host cell nucleus could function in the bisection of 
MLV unspliced RNA fates by routing this dimeric gRNA to plasma membrane sites of 
assembly. 
 Consistent with results from general transcription inhibition, specific Tet-
repression of MLV transcription led to a decline in gRNA packaging that was more rapid 
than the decline in virion production; however, gRNA packaging levels did not decrease 
to the same extent after Tet-repression as was observed after global inhibition with ActD.   
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The more moderate decline in gRNA packaging from specific Tet-repression of MLV 
transcription could indicate that other factors, which are involved in the initial 
recruitment of MLV gRNAs, are disrupted by general transcription inhibition but not by 
specific inhibition of MLV transcription. 
 Disruptions to protein shuttling between the nucleus and cytoplasm caused by 
ActD treatment may sequester cellular or viral factors that function in MLV gRNA 
recruitment.  Cellular factors demonstrated to be disrupted by ActD treatment include the 
protein components of heterogenous nuclear ribonucleoprotein complexes (hnRNPs) (159) 
which are highly abundant in the host cell nucleus and are among the first proteins to 
bind nascent Pol II transcripts (44, 45).  Candidates among the transcription-dependent 
hnRNPs that may differentially effect MLV versus HIV-1 unspliced RNA pools are 
hnRNP A1 and hnRNP A2, which are retained in the cytoplasm after ActD treatment 
(159).  HIV-1 over-expression has been shown to induce the cytoplasmic retention of 
hnRNP A1 (125), and over-expression of either hnRNP A1 or A2 decreases virion 
production and increases nuclear retention of HIV-1 unspliced RNAs (85).  Disruption of 
hnRNP A2-response elements leads to increased nuclear retention of HIV-1 unspliced 
RNA and decreased packaging (12).  These data suggest that hnRNP proteins may 
function in the localization and initial recruitment of HIV-1 gRNAs to sites of assembly.  
HIV-1 unspliced RNAs, which likely form dimers in the cytoplasm (128), are not, 
therefore, sequestered from these potential recruitment cofactors after ActD treatment, 
but MLV gRNAs, which likely form nuclear dimer partner associations, might be 
compartmentally isolated from these cellular RNA binding proteins after ActD treatment. 
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 Alternatively, the disruption to nuclear-cytoplasmic shuttling could impact a viral 
factor involved in the initial recruitment of MLV gRNA.  MLV Gag has not been 
demonstrated conclusively to shuttle between the nucleus and cytoplasm.  However, 
Nash et al. (137) reported that 18% of MLV-infected cell-associated Gag 
immunoprecipitated from nuclear fractions.  Gag trafficking through the nucleus at late 
phases in replication is not widely established among retroviruses, but studies of avian 
sarcoma virus have shown that a portion of Gag transits through the nucleus en route to 
sites of assembly (176-178).  Gag, in particular the NC domain of Gag, has been 
demonstrated to function in activating gRNA dimerization in vitro (68).  The NC domain 
of Gag also mediates gRNA recruitment (72, 168, 169).  General transcription inhibition 
could sequester Gag in the cytoplasm and prevent interaction with nuclear MLV 
unspliced RNAs.  Tet-repression of MLV transcription might not alter this trafficking 
pattern, and the more modest decline in gRNA recruitment relative to that seen with 
general transcription inhibition could be indicative of the singular effect of reducing 
nascent transcripts but not exposure to the trans acting protein component of the initial 
retroviral RNP. 
 Perhaps the simplest explanation for the discrepancy between the declines in 
gRNA packaging from Tet-removal versus ActD treatment is that the repression in the 
Tet-inducible system results in an incomplete shut off of MLV transcription.  Media from 
Tet-regulated MLV expressing cells that were never exposed to tetracycline contain low 
levels of 7SL and MLV gRNAs (~30-fold less than On levels and ~10-fold above no 
RNA controls).  When used to initiate a spreading infection in fresh target cells, 
supernatants from uninduced cells gave rise to RT positive supernatants at 5 days post 
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infection, which was 2 days later than cells infected from a comparable volume of 
supernatants from induced cells.  Together, these data suggest that even uninduced Tet-
regulated MLV expressing cells produce low levels of virus.  Thus, low level expression 
of MLV transcripts may continue to be recruited into assembling virions.  Low level 
MLV expression could then account for the more moderate effect on gRNA packaging 
seen here by specific Tet-repression.  The observed more rapid decline in gRNA 
packaging relative to virion production might then represent a direct effect of inhibiting 
MLV expression rather than an indirect effect on an additional viral or cellular factor 
involved in gRNA recruitment. 
  Increases in the randomness of MLV dimer partner associations and in 
recombination at late time points suggest the existence of an alternate pathway of initial 
gRNA recruitment.  However, the levels of increase in both randomness of dimerization 
and recombination do not reach the level of randomness exhibited by HIV-1.  Therefore, 
this alternate pathway continues to exhibit dimer partner associations which are 
consistent with gRNA recruitment taking place prior to nuclear egress. 
 The mode of nuclear export may function further in the subcellular spatial-
segregation of partitioned MLV gRNAs and viral mRNAs.  Retroviruses use different 
pathways to export their unspliced RNAs from the nucleus, and the manner of export 
affects subsequent protein functions as well as the cytoplasmic compartmentalization of 
viral unspliced RNAs.  How MLV unspliced RNA is exported from the nucleus is not 
known, but the mode of unspliced RNA nuclear export is known for other retroviruses.  
To translocate from the nucleus to the cytoplasm, a constitutive transport element (CTE) 
on Mason-Pfizer monkey virus (M-PMV) unspliced RNA interacts directly with the 
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cellular nuclear export factor Nxf1 (32, 78).  In HIV-1, the viral protein Rev mediates 
translocation of HIV-1 unspliced RNA from the nucleus to the cytoplasm through 
interaction with a Rev response element in the unspliced viral RNA (31) and the cellular 
shuttling protein Crm1 (138).  Changing the mode of nuclear export of HIV-1 gag-pol 
mRNAs from the native Rev/RRE/Crm1 pathway to the CTE/Nxf1pathway restored Gag 
trafficking to cellular membranes and HIV-1 budding in murine cells (200).  Recently, 
Moore et al. (128) showed that HIV-1 co-expressed gRNAs randomly associate and 
exhibit normal high level recombination when they both exit the nucleus via the same 
(either Crm1 or Nxf1) pathway.  However, when co-expressed HIV-1 gRNAs exit 
through different pathways, they exhibit non-random dimer associations or preferential 
self-associations, and lower levels of recombination (128).  In the context of our results 
here, in which MLV unspliced RNAs appear to sort in the host cell nucleus, nuclear 
export of monomeric viral mRNAs versus dimeric gRNA likely further spatially 
segregates these RNA pools (Fig. 3-5). 
 Previous work in our lab on the packaging of mY RNAs provides additional 
support for the model of nuclear gRNA recruitment.  Mouse mY RNAs are among the 
most highly packaged noncoding cellular RNAs by MLV (149).  While mY RNA levels 
are severely reduced in cells that lack Ro60 (185), the cognate cellular mY RNA-
associated RNP protein, virions produced from Ro60 knockout cells continue to package 
very high levels of mY RNAs (65).  This suggests that mY RNAs may be recruited early 
in their biogenesis within the host cell nucleus.  The recruitment of cellular mY RNAs, 
therefore, indicates a nuclear subassembly step in MLV replication which may represent 
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a nuclear intersection between cellular noncoding mY RNA recruitment and the initial 
recruitment of MLV gRNAs. 
 The findings here, which support an early bisection in MLV unspliced RNA fates, 
add to the growing evidence for a nuclear subassembly step in MLV replication.  This 
nuclear step in MLV assembly contrasts with the recent findings of cytoplasmic gRNA 
dimerization in HIV-1 (128).  The results here suggest a distinct RNA trafficking 
pathway that transits dimeric MLV gRNA rapidly and directly from the nucleus to 




Figure 3-5. Model of nuclear MLV unspliced RNA sorting.  A model for the bisection 
of MLV unspliced RNA into gRNA and viral mRNA fates, based on observations 
reported here.  The majority of MLV gRNAs are subject to an early dimerization event.  
However, a subset of MLV gRNAs may escape early dimerization and form dimer 
partner associations more randomly later.  The oval represents the nucleus, and the gray 
box within the nucleus indicates the likely stages of MLV unspliced RNA biogenesis 





An RNA structural switch in the 5’ leader of Moloney murine leukemia virus 




 Retroviral genomic RNAs (gRNA) are recruited in pairs.  This fundamental 
property of retroviruses suggests that the mechanism of gRNA pair associations is 
coupled to how gRNAs are recruited into assembling virions.  Recent in vitro studies of 
Moloney murine leukemia virus (MLV) gRNA interactions with the nucleocapsid (NC) 
protein, a domain of Gag, support an RNA switch model whereby dimerization exposes 
cis-acting gRNA residues that participate in high affinity interactions with NC, as part of 
Gag.  These high affinity interactions then are hypothesized to recruit the gRNA dimer 
into assembling virions.  Further testing this model in collaboration with work performed 
here, Miyazaki et al (124) quantified the number of high affinity NC interactions of in 
vitro transcribed RNAs corresponding to wild type Ψ (ΨWT) and a dimerization-defective 
mutant Ψ (ΨM) that contained GNRA residues which stabilized Ψ-hairpins.  The ΨWT 
RNA bound ~12 NC molecules with high affinity (Kd ~17 nM), and the ΨM RNA, in 
contrast, only bound 1 NC molecule with high affinity.  Here, the in vivo packaging of 
ΨM-containing full length MLV gRNAs was compared to the packaging of ΨWT-
containing gRNAs, and results indicated that ΨM mutations which disrupt dimerization in 




gRNA packaged into virions produced from ΨM constructs also exhibited lower 
thermostability than ΨWT gRNAs, which indicates an in vivo dimer stability defect that 
parallels the in vitro phenotype.  Using a mutant NC that disrupts the hydrophobic cleft of 
the zinc finger and impairs high affinity RNA binding, NC function in specific (ΨWT) and 
nonspecific (ΨM) gRNA packaging was quantified, and results indicated that the 
relatively efficient packaging of ΨM gRNAs produced by transient transfection was likely 
due to low affinity NC-RNA interactions.  Our results here provide in vivo support for an 
RNA conformational switch model of gRNA packaging, and they also demonstate the 
potential use of cis and trans-acting mutants with defects in gRNA dimerization and/or 
packaging in the further study of our model of MLV nuclear gRNA dimerization.
 
Introduction 
 Retroviruses selectively package two unspliced genomic RNAs (gRNAs) from a 
large excess of cellular mRNAs.  The nucleocapsid domain (NC) of Gag has been 
demonstrated to function in the specific recruitment of retroviral unspliced RNAs which 
contain cis-acting packaging signals (called Psi or Ψ) (36, 168).  The exact mechanism by 
which NC mediates gRNA recruitment and the specific incorporation of Ψ-containing 
RNAs into assembling virions is an area of active research (36). 
  In vitro structure and function analysis of NC-Ψ interactions suggests that 
Moloney murine leukemia virus (MLV) uses an RNA switch mechanism for gRNA 
packaging whereby gRNA dimerization functions to switch the RNA into a conformation 
that exposes high affinity NC binding sites (34, 36).  The previous findings in support of 
this model include observations of high NC binding affinities for synthetic 
oligoribonucleotides that contain portions of Ψ (Kd of ~55 nM) (35).  Also, NMR 
analysis of a 101 nucleotide (nt) mutant Ψ-construct, designed to remain monomeric but 
retain intramolecular base pairing of the dimer, revealed a single NC-Ψ interaction 
between the CCHC zinc finger of NC and UCUG nucleotides on the RNA (34).  
Synthetic oligoribonucleotides with similar Py-Py-Py-G sequences (Py = pyrimidines) 
bound NC with high affinities between 94 to 315 nM (42). This motif and similar UCUG 
sequences are more abundant in the 5’ UTR and Ψ region than in the rest of the gRNA.  
Because most of these sequences are sequestered by base pairing in the monomeric form 
of the RNA, the observations of high affinity NC binding to this motif supports a model 
in which dimerization functions to expose single stranded UCUG motifs that then bind 
NC with high affinity. 
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 The MLV Ψ within the 5’ UTR functions in both gRNA dimerization and 
packaging.  Pair associations near the 5’ ends of MLV gRNAs, termed the dimer linkage 
structure (DLS), were first visualized by electron microscopy (134).  The importance of 
this region on gRNA packaging was demonstrated by a 353 nt deletion within the 5’ UTR 
of MLV gRNA that reduced gRNA packaging to undetectable levels by northern blot 
(115).  A ~70 nt portion of this region was shown to be sufficient to confer packaging of 
heterologous RNAs into MLV particles, and it was termed the core encapsidation signal 
(CES) (2, 129).  In vitro synthesized RNAs of this region, including downstream 
sequences that extend into gag, spontaneously form dimers in a process that can be 
catalyzed by NC (162).  Using oligo-accessibility mapping and competition experiments, 
Prats et al. (162) demonstrated that nts 280 to 308 and 310 to 329 (nt positions relative to 
the 5’ end of the gRNA) function in the DLS of MLV.  Additional sequences that 
function in the DLS were subsequently mapped to nts 204 to 228 (152).  Ly and Parslow 
(111) used point mutations and antisense inhibition to show that nts 204 to 228 and 283 
to 298 function as a bipartite signal in MLV gRNA dimer initiation and DLS stabilization 
in vitro.  These regions were termed dimer initiation site 1 and 2 (DIS-1 and DIS-2).  The 
region of MLV Ψ from DIS-1 through the end of the CES forms four putative stem loops 
(termed DIS-1, DIS-2, SL-C and SL-D) which have been extensively studied and further 
demonstrated to function in gRNA dimerization and NC-dependent gRNA packaging 
(Fig. 4-1) (36).   
 The NC domain of Gag specifically recruits MLV gRNA into assembling virions 
(13, 38, 168). The importance of NC in MLV gRNA packaging was first demonstrated by 
point mutations in the zinc finger of the NC domain that disrupted gRNA packaging and 
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infectivity (72, 121).  The specificity of the MLV NC domain for recruitment of MLV Ψ-
containing RNAs was demonstrated using chimeric Gag polyproteins (14).  Packaging of 
MLV Ψ-containing RNAs was achieved by swapping the human immunodeficiency virus 
type 1 (HIV-1) NC domain for the MLV NC domain (14).  Thus, the MLV NC domain is 
sufficient to confer packaging of heterologous RNAs that contain the MLV Ψ into HIV-
1-derived virus like particles. 
 The MLV NC domain participates in low and high affinity interactions which 
may function in the RNA switch mechanism of gRNA packaging.  In addition to its role 
in specific gRNA packaging, the NC domain has been shown to catalyze gRNA 
dimerization through low affinity gRNA-protein interactions (68, 162).  In the context of 
the RNA switch model of MLV gRNA packaging mentioned above, this suggests that 
low affinity NC-gRNA interactions lower the activation energy of gRNA dimerization 
which then exposes high affinity NC binding sites on the gRNA.  Using an in vitro NC 
binding assay and isothermal titration calorimetry, Miyazaki et al. (124) quantified the 
number of high affinity NC binding sites in 476 nt in vitro transcribed Ψ-containing 
RNAs with a wild type Ψ (ΨWT) or a dimerization mutant Ψ (ΨM) (Fig. 4-1A).  The ΨWT 
RNA bound approximately 12 molecules of NC with high affinity (Kd ~17 nM) in 
contrast to the ΨM RNA which bound 1 molecule of NC with high affinity (Kd ~29 nM) 
(124).  These data directly support the model that gRNA dimerization functions as an 
RNA switch that exposes additional high affinity NC binding sites. 
 Here, the packaging of gRNAs that contain ΨM dimer disrupting mutations or 
three Ψ sub-deletions were quantified relative to ΨWT-containing gRNAs in a tissue 
culture-based packaging system(Fig. 4-1A and 1B).  MLV gRNA packaging was 
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measured using RNA isolated from MLV virions produced by transient transfection with 
a ΨWT competitor, and by single-copy integrated proviruses.  Results indicated that 
mutations which disrupt dimerization and NC binding in vitro inhibit gRNA packaging in 
vivo.  Furthermore, the NC dependence of gRNA packaging was addressed using an NC 
point mutant with a change that disrupts the hydrophobic cleft of the NC zinc finger 
pocket which NMR data suggest mediates specific NC-gRNA binding.  Finally, ΨM-
containing gRNAs were used to test predictions from the model presented in Chapter III 
that nuclear MLV unspliced RNA bifurcation and dimer partner associations lead to 
MLV gRNA preferential self-associations.  Together, our results provide further evidence 
that gRNA dimerization acts as a switch to expose high affinity NC binding sites that can 
then function in gRNA recruitment, and our preliminary observations suggest that 







Materials and Methods 
 Plasmids for virology.  MLV RNA packaging was assessed using derivatives of 
the MLV-based gag-pol-puro plasmid, pGPP (pSRK876-15) (indicated in the figures 
here as “WT”), which contains an intact provirus modified by the replacement of the env 
open reading frame with a puromycin N-acetyltransferase gene (puroR) driven by a 
simian virus 40 (SV40) promoter (158) (Fig. 4-1C). The “classic Ψ” deletion of Mann 
and Baltimore (Δ215-568) (pEG455-11) (115), sub-deletions Δ215-367 (pEG455-8) and 
Δ375-568 (pEG455-24), and the ΨM mutant (pSRK910-1) were generated by overlap 
extension PCR, sequenced, and used to replace the corresponding portions of pGPP (Fig. 
4-1A and 1B).  The W35G NC mutation was generated by overlap extension PCR and 
used to replace the corresponding portion of pGPP; the resulting plasmid used here was 
pEG479-1.  The double mutant containing ΨM and W35G NC, pSRK1342-3 was 
generated by restriction fragment subcloning. The helper plasmid pNGVL-3’-gag-pol, 
which expresses MLV Gag and Gag-Pol from a 5’ leader-deleted transcript driven by the 
CMV promoter, has been described previously (225). The competitor plasmid pBAG 
encodes a retroviral vector with a wild type MLV 5'-UTR and lacZ  (163). 
 For RNA capture experiments, MΨPuro (pAM86-5 (98))-derived vectors were 
created that contained short sequences from pol (nts. 2741-3141 from MLV transcription 
start site, BclI-MfeI) which were complementary to the biotinylated oligo (the oligo 
binding domain, OBD) used for the captures.  These MΨPuro-OBD plasmids were 
subcloned to contain either ΨWT (pEG402-1) or ΨM (pEG427-3).  ΨWT pEG402-1 was co-




Figure 4-1.  Ψ constructs and MLV-based gag-pol-puro (GPP) cassette.  (A), location 
of ΨWT DIS-1 and core encaspsidation signal (CES) hairpins (DIS-2, SL-C, and SL-D) 
and the corresponding hairpin stabilizing mutations in the ΨM dimerization mutant, 
indicated as gray bases in ΨM.  (B), location of the three Ψ deletions (ΨΔCES—a deletion 
of DIS-1 thru SL-D; Ψ-—a “classic Ψ” deletion of Mann et al. (115); and ΨΔ193—a 
deletion sequences downstream of the CES but within the classic Ψ) in relation to the 
PBS, the four Ψ stem loops, and the first base of gag, nt. 621.  (C), the location of Ψ and 
the puromycin resistance expression cassette (PSV40; puroR) in the GPP-derivative 
plasmids used for all the work reported here.  Portions of Fig. 4-1, A & B, were adapted 
from Miyazaki et al. (124). Figures are not to scale. 
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 type in RNA capture assays, and a ΨM version of pAM86-5 (pEG427-6) was 
cotransfected with pEG427-3 to test the randomness of ΨM gRNAs. 
 All riboprobe templates were derivatives of pBSII SK(+) (Stratagene). The insert 
in pEG467-10, which was generated by PCR and subcloned into the pBSII SK(+) EcoRV 
site, included complementarity to portions of both the MLV 5’ untranslated region (nts. 
55-214) and 100nt of 7SL RNA (149). pSRK38-7 is an HIV-1 pol-7SL chimeric 
riboprobe template described previously and used here as a probe for 7SL RNA (150). 
pSRK1216-71 was generated by sequentially subcloning a Cla I-Ssp I fragment of lacZ 
and a Bgl II-Xba I MLV pol fragment from pNCA (28) into pBSII SK(+) digested from 
Cla I-EcoRV and BamHI-Xba I, respectively.  The insert in pEG349-1 included 92 nts. of 
pol (nts. 3050-3141) and an adjacent 324 nts. of SV40 promoter sequences. 
 Cells and virus.  293T cells (human embryonic kidney cells expressing SV40 T 
antigen) were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% 
fetal calf serum and 1% penicillin-streptomycin.  Virus was produced by transient 
transfection of the pGPP or pNGVL-3’-gag-pol plasmids into 293T cells by calcium 
phosphate precipitation (225). Virus-containing media were harvested at 24, 36, and 48 
hours post transfection, pooled, filtered through a 0.2-μm filter, and stored at -70ºC prior 
to use.  Some of this transiently produced virus was used to infect ET cells, which are a 
293T derivative that constitutively expresses ecotropic envelope (158).  These infections 
were used for measuring titers and creating the pools of stably integrated proviruses used 
in later experiments.  Virus-containing media harvested from the ET cell pools were 
harvested and analyzed for RT content and packaged RNA content using the assays 
described below.  
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 Exogenous reverse transcriptase (RT) assay.  Virus was harvested, filtered 
through 0.2-μm filters, and stored at -70 ºC.  Quantitative RT assays of media 
supernatants as a means of quantifying virion production were performed using 
modifications of a standard protocol (70) as described previously (172). Products were 
quantified by PhosphorImager analysis. 
 Ribonuclease protection assays. Cellular RNA was extracted using TRIzol ® 
reagent (Invitrogen) according to the manufacturer’s protocol.  To generate riboprobes 
for measuring cellular gRNA/7SL levels, two riboprobes were used.  To detect 7SL, 
pSRK38-7 was linearized with SalI and transcribed using T7 RNA polymerase (Promega) 
and [γ-32P] rCTP to create a 344 nt transcript which protected 101 nt of 7SL RNA.  To 
detect MLV gRNA, pSRK1216-71 was linearized with XhoI and transcribed using T3 
RNA polymerase (Promega) to generate a 693 nt transcript which protected 206 nt of 
MLV pol RNA (nts. 5120-5325).  In packaging competition experiments, pSRK1216-71 
693 nt transcript was used to detect both Test RNAs (by protecting a 206 nt pol fragment) 
and the Control pBag vector (by protecting a 408 nt lacZ fragment). 
 For measuring viral gRNA/7SL ratios and for RNA capture assays, RNA was 
isolated from pelleted virions using a previously described proteinase K-based extraction 
protocol (53) and quantified by RPA using a 365 nt chimeric MLV-7SL riboprobe 
templated by linearized pEG467-10, which protected 160 nt of Ψ M or 163 nt of wild type 
and Ψ deletion mutant gRNAs, plus 100 nt of 7SL RNA.    
 For measuring gRNA ratios in RNA capture assays, pEG349-1 was linearized 
with HindIII and transcribed with T3 RNA polymerase (Promega) to generate a 491 nt 
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transcript which protected 440 nts. of MΨPuro-OBD-type gRNAs (designated as “MLV” 
in Fig. 4-6) and 324 nts. of MΨPuro-type gRNAs (designated as “MΨPuro” in Fig. 4-6). 
 Previously described RPA approaches (149) were modified by extending 
hybridization times to 16h and digesting using only RNase T1. Bands were quantified by 
PhosphorImager and adjusted for the number of radiolabelled Cs protected. RNA 
packaging was quantified by normalizing the amount of MLV RNA in each lane to the 
amount of co-packaged 7SL. 
 Non-denaturing northern blot.  MLV viral RNA was isolated from pelleted 
virus by the proteinase K-based extraction protocol above and resuspended in 1× TENS 
buffer (10 mM Tris pH [8.0], 1 mM EDTA, 1% (w/v) SDS, and 100 mM NaCL).  
Samples were incubated for 10 min at the indicated temperatures then placed on ice until 
loaded on a non-denaturing 0.7% (w/v) agarose gel. RNA was electrophoretically 
transferred to a Zeta-Probe® GT nylon membrane (Bio-Rad).  Prehybridization was 
performed at 45ºC for 2h in 6× SSC (1× SSC is 0.15 M NaCL plus 0.015 M sodium 
citrate) – 5× Denhardt’s solution–0.5% sodium dodecyl sulfate (SDS) – 0.025 M sodium 
phosphate – 625 μg/ml of denatured salmon sperm DNA.  The oligonucleotide probe was 
an anti-MLV R probe:  5’-actgcaagagggtttattggatacacgggtacc-3’ that was 5’-end labeled 
using [γ-32P] ATP (Perkin-Elmer) and T4 polynucleotide kinase (NEB).  Hybridization 
was performed at 45ºC for 16 h.  The blot was washed twice with 2× SSC – 0.1% (w/v) 
SDS at 50ºC for 15 min followed by 2 washes with 0.33× SSC – 0.1% (w/v) SDS at 50ºC 
for 15 min.  Washed blots were exposed to PhosphorImager screens for subsequent 
ImageQuant analysis/band quantification. 
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 RNA capture assay.  The RNA capture assay protocol--an oligo-mediated dimer 
pull down assay--was adapted from that previously described and used to measure the 
randomness of dimer partner associations (53).  The modifications included increasing 
the number of washes to 7 and increasing the stringency of the washes by lowering the 






Mutations that inhibit dimerization and NC binding in vitro inhibit RNA packaging 
in vivo.   
The effects of Ψ region mutations on MLV RNA packaging were assessed 
initially by quantifying RNA packaging levels in virions produced by transient 
transfection. An MLV-based vector construct, pGPP, containing the 5’ terminal two-
thirds of the MLV genome, including the 5’-UTR, gag and pol genes, and a puromycin 
N-acetyltransferase expression cassette in place of env (158) was used to generate both 
viral proteins and genomic RNAs (gRNAs) (Fig. 4-1C). Derivatives of pGPP containing 
wild type or mutant 5’-UTRs (Fig. 4-1A and 1B) were expressed in 293T cells, and 
gRNA levels in the cells and the resulting virions were determined by RNase protection 
assay.  Virions were normalized with 7SL RNA, a host RNA that is packaged in HIV-1 
and MLV at levels proportionate to virion proteins (149, 150). Results are shown in 
Figure 4-2. 
Intracellular levels of wild type and mutant gRNAs differed by less than three-
fold (Fig. 4-2A), and virus production (as determined by reverse transcriptase (RT) 
activity) was roughly proportionate to intracellular viral RNA levels.  This indicated that 
the 5’ UTR mutations did not significantly affect transcription, translation, or virion 
assembly. However, deletion of either the core encapsidation region (Δ215-367, ΨΔCES) 
or the extended packaging region (Δ215-568, Ψ
-
) (115) reduced RNA packaging to 
roughly 1% of wild type levels.  In contrast, deletion of a large fragment located 
immediately downstream of the core encapsidation region (Δ375-568, ΨΔ193) decreased 
 99
 
packaging by less than two-fold (Fig. 4-2B and 4-2C). Packaging levels measured by 
quantifying gRNA per virion, normalized to either RT or to 7SL RNA packaging, yielded 
very similar results (Fig. 4-2B and 4-2C), and both measures indicated that the ΨM is 
packaged at ~8% of wild type levels. Thus, the UTR variants that were dimerization 
defective in vitro were also packaging defective in virus. When normalized by RT levels, 
the puromycin-resistant colony forming unit (cfu) titer of ΨM mutant virion-containing 
media was about 10-fold less than either wild type or ΨΔ193, and both Ψ- and ΨΔCES titers 
were reduced an additional 10- to 20-fold (data not shown). Thus, reverse transcription 
was not altered by these 5’ UTR mutations. 
Although packaging levels of the ΨM mutants were reduced in the above 
experiments, the over-production of the mutant RNAs in transfected cells might have 
caused packaging levels to be artificially high, since retroviruses can efficiently package 
RNAs that lack Ψ sequences under conditions in which the native genomes are not 
present (48). Therefore, we next measured packaging efficiencies using a competition 
assay, in which “test” genomic RNAs (gRNAs) containing either wild type or mutant 5’ 
UTRs were co-expressed with a control gRNA containing a wild type 5’ UTR, and ratios 
of test to control gRNAs were determined in both virus and cells (Fig. 4-2D). As shown 
in Fig. 4-2D, the presence of a wild type competitor gRNA depressed packaging of both 
the ΨM and ΨΔCES mutants to ~ 1% of wild type levels, suggesting that at least some Ψ 
mutant RNA packaging observed under the transient transfection conditions above was 
nonspecific. 
Finally, gRNA packaging was assessed in virions produced by cells that contained 




with GPP derivatives at low (<0.01) multiplicity of infection were used to generate 
virions, and the virion and intracellular levels of the respective gRNAs were compared. 
As shown in Fig. 4-2E-2G, ΨM gRNA packaging levels were reduced 100-fold relative to 
wild-type levels under these conditions, which resemble those that occur during natural 
infection.  These results are consistent with those obtained using the competition assay, 
and provide further evidence that much of the ΨM packaging observed under transient 
transfection conditions was due to non-specific packaging of the overproduced RNA. 
Inefficiently packaged ΨM gRNAs exhibit reduced thermal stability 
 The relatively efficient encapsidation of ΨM gRNAs under transient transfection 
conditions provided a way to generate ΨM gRNAs in sufficient quantities for examination 
on non-denaturing northern blots, to test whether or not the encapsidated RNAs existed in 
the metastable dimer linkage characteristic of wild type MLV gRNAs (82). To address 
this, vectors with ΨWT, ΨM, and ΨΔCES – containing 5’ UTRs were overexpressed by 
transient transfection, and virion RNAs were purified under non-denaturing conditions. 
Virion RNA samples normalized for gRNA content were subjected to heat treatments 
based on previously determined genome melting profiles (82), and examined on non-
denaturing northern blots (Fig. 4-3). The results showed that wild type gRNAs displayed 
properties as described previously (58, 81): running as a fairly discrete dimer when 
unheated, displaying a small amount of monomer but principally residual dimer at 58 °C, 
and denaturing fairly completely to the monomer form—albeit with a significant amount 
of the RNA degradation characteristic of retroviral gRNAs—when incubated at 65 °C 
(Fig. 4-3). In contrast, unheated ΨM and ΨΔCES virion gRNAs appeared as diffuse, slowly-
migrating bands that resolved mainly to monomers or a smear with reduced mobility at 
 
Figure 4-2.  RPA quantification of gRNA packaging for gRNAs containing wild type 
and mutant Ψs.  (A-C) Packaging of Ψ mutant gRNAs in virus produced by transient 
transfection. (A) Intracellular expression of Ψ mutant RNAs. MLV wild type and Ψ 
mutant gRNA levels were normalized to 7SL RNA by RNase protection assay (RPA) of 
total RNA extracted from transiently transfected cells. Lane 1: mock-transfected cell 
sample; lane 2: cells transfected with pGPP ΨWT; lane 3: cells transfected with pGPP 
derivative with ΨM; lane 4:  with ΨΔCES; lane 5: with Ψ-; lane 6: with ΨΔ193; lane 7: cells 
transfected with pNGVL-3’, which is a helper construct that expresses MLV Gag and Pol 
but contains a large 5’ UTR deletion; and lane C: no RNA control. Migrations of probe 
fragments protected by MLV wild type and mutant gRNAs, and by 7SL RNA, are 
indicated on the right. (B) Packaging of Ψ mutant RNAs. RPA of virion RNA extracted 
from media samples normalized by RT activity. The helper plasmid, pNGVL-3’-gag-pol, 
lacks native 5’ UTR sequences, and thus no MLV-derived fragment was detected in lane 
6. (C) Quantification of gRNA RNA packaging in virions produced by transient 
transfection. Reported as percent of wild type levels, using 7SL to normalize number of 
virions. Data are from three separate RPAs of viral RNA as shown in (B).  (D) Packaging 
of Ψ mutant gRNAs under competition with co-expressed wild type gRNAs. RPA of cell 
and viral RNA from 293T cells transiently co-transfected with plasmids expressing test 
gRNAs (Ψ variant GPPs) and a wild type 5’ UTR control gRNA (pBAG (163)).  
Calculation of %WT packaging was as described in text. (E-G) Packaging of Ψ mutant 
gRNAs under single copy expression conditions (E) RPA of cellular RNA extracted from 
cells expressing MLV Ψ variants as single stably integrated proviruses.  (F) RPA of 
gRNA in virions produced by single integrants.  Migration of probe fragments protected 
by MLV gRNA and 7SL are indicated on the right.  (G) Quantification of gRNA/7SL 
ratios from three separate RPAs of viral RNA. For all RPAs, lanes include undigested 
probe (P); RNA size markers (M); and digested probe alone control (C). MLV gRNA 
protected fragments occasionally run as two bands due to a single-base mismatch 
between the 5’ end of the gRNA and the 3’ end of the riboprobe which cleaves under 
conditions of excess RNAse T1 to RNA.  The MLV gRNA riboprobe protects the 5’ 
UTR region of MLV gRNA which contains the different mutations tested, and this 
accounts for discrete differences in the size of protected fragments exhibited by the 
mutant MLV gRNAs versus the wild type MLV gRNAs.  7SL protected fragments 
appear as multiple bands possibly due to the existence of different 7SL isoforms and 
experimental differences in the degree of RNase cleavage.  The altered mobility 7SL 
bands in lane 6 (B) and in lane 4 (F) were likely due to minor variations in salt 







58 °C, followed by nearly complete denaturation to the monomer form at 65 °C (Fig. 4-3). 
This later thermal denaturation profile is highly reminiscent of the so-called “tethering” 
interactions that have been described within and between co-packaged MLV gRNAs in 
RNA regions outside the dimer linkage region (82). This suggests that the slow migrating 
forms of both ΨM and ΨΔCES RNAs were retarded largely by non-specific interactions that 
occur during condensation of the RNAs in assembling virions rather than by specific, 
more stable interactions involving their 5’ UTRs. Together, these findings demonstrate 
that when ΨM RNAs are packaged, they do not exist in the dimer linkage with a fairly 
discrete melting point that is characteristic of wild type MLV gRNAs, but instead exist in 
heterogeneous form that is condensed by various tethering interactions, at least most of 
which are significantly less thermostable than wild type gRNAs’ dimer linkages. 
Packaging of MLV ΨWT and ΨM gRNAs is NC dependent.   
 The elevated level of packaging of ΨM gRNAs observed in transient transfection 
experiments above suggested that overexpression of mutant ΨM gRNAs led to the 
observed relatively efficient packaging.  The subsequent analysis of packaging in 
competition and single-integrated copy experiments showed a further 10-fold drop in ΨM 
gRNA packaging, which further supports the notion that overexpression led to increased 
nonspecific packaging.  
  Because the NC domain of the Gag polyprotein mediates specific recruitment of 
MLV gRNA (14), the specificity of gRNA recruitment in transient transfection 
experiments could be assessed with an NC mutant that is defective in gRNA packaging.  
ΨWT and ΨM gRNA packaging were, therefore, quantified in the context of MLV Gag 




Figure 4-3. Non-denaturing northern analysis of wild type, ΨM, and ΨΔCES 
containing gRNAs.  Virion RNA samples were normalized to contain roughly the same 
number of gRNAs per lane and were subjected to the indicated treatments as described in 
the text. Arrowheads at right indicate the mobilities of wild type products. That the 
slightly reduced mobility of the wild type dimeric RNA observed at 58o, relative to the 
unheated sample, is consistent with previous findings (58, 81). 
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a glycine in place of a tryptophan at amino acid number 35 of the NC protein.  This 
mutation disrupts an aromatic amino acid in the hydrophobic cleft of the zinc finger 
domain that binds sequences in ΨWT gRNAs with high affinity (37).  The W35G NC 
mutant is defective for gRNA packaging in vivo (71, 226) and NC-Ψ interactions in vitro 
(Michael Summers, personal communication).  The NC W35G mutant in the context of 
ΨWT (Fig. 4-4, lanes 4 and 5) disrupted gRNA packaging 2 to 3 fold more than the ΨM 
mutations with wild type NC (Fig. 4-4, lane 3).  The gRNA packaging levels in the 
W35G mutant were about 1/20th wild type levels.  The levels of gRNA in the double 
mutant, ΨM and W35G, were further decreased to less than 1% of wild type levels.  These 
data indicate that, while the ΨM mutant exhibits reduced NC binding in vitro and gRNA 
packaging in vivo, residual ΨM gRNA packaging is still NC dependent. 
 Packaging quantification in transient transfection experiments can yield variable 
results.  For example, we observed 2 to 3 fold differences in gRNA packaging in virions 
produced by transfection with different plasmids of identical genotype, ΨWT W35G NC 
mutant (Fig. 4-4, lanes 4 and 5).  Also, the level of ΨM gRNA packaged in the RPA 
shown (Fig. 4-4, lane3) was about 3 fold greater than previous experiments reported 
above.  To test whether or not varying expression would lead to parallel changes in 
gRNA packaging, we performed 3 fold serial dilutions of DNA used in the transfection of 
one of the double mutants (Fig. 4-4, lanes 7 through 9).  Indeed, the gRNA packaging 
levels declined concomitantly with the amount of DNA used for transfection (Fig. 4-3, 
lanes 7 through 9).  These data suggest that MLV proteins are not a limiting component 
in gRNA packaging, and further demonstrate that transient transfection experiments used 




Figure 4-4. RPA quantification of ΨWT and ΨM gRNAs with wild type or W35G 
mutant NCs.  Packaging of ΨWT and ΨM gRNAs in WT NC and W35G NC mutant 
virions produced by transient transfection and analyzed here by RPA.  Viral RNA 
samples were normalized to RT activity.  Migrations of probe fragments protected by 
MLV wild type and mutant gRNAs, and by 7SL RNA, are indicated on the right. Lanes 4 
and 5 are RNAs from virus produced by transfection with different plasmid preparations 
of ΨWT W35G NC mutant pGPPs.  Lanes 6, 7-9, 10, 11 and 12 are RNAs from virus 
produced by transfection with different plasmid preparations of ΨM W35G NC mutant 
pGPPs.  Lane 8 and 9 were 3-fold serial dilutions of the same preparation of the ΨM 
W35G NC mutant pGPP plasmid used for lane 7, represented by the gray triangle below 
the lane numbers.  Lanes include undigested probe (P); RNA size markers (M); and 
digested probe alone control (C).  ΨM W35G MLV gRNAs appear as two bands due to a 
single-base mismatch near the 5’ end of the gRNA with the 3’ end of the riboprobe which 
produces two bands under conditions of excess RNase T1 to RNA.  The gRNA levels 
normalized to 7SL are quantified below the RPA as the % of ΨWT with a WT NC domain. 
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W35G NC mutant is defective in gRNA packaging but does not disrupt gRNA 
dimerization.   
 The MLV NC domain takes part in high (124) and low affinity (39, 161) RNA 
interactions which function in both gRNA recruitment (72, 168) and activation of gRNA 
dimerization (68, 162), respectively (reviewed in (38) and (170)).  Because NC functions 
in both packaging and dimerization, we sought to determine the effect of the W35G 
mutation on gRNA dimer stability in vivo.  To determine whether or not the W35G 
mutation disrupts ΨWT gRNA dimer stability, we performed a nondenaturing northern 
blot on viral RNA from W35G mutant virions produced by transient transfection (Fig. 4-
5).  The northern blot was normalized for virion abundance by RT activity.  As quantified 
in the RPA above, the W35G NC mutant exhibited decreased gRNA packaging relative 
to wild type NC (Fig. 4-5).  However, in contrast to the diffuse dimers exhibited by ΨM, 
ΨΔCES, and Ψ- gRNAs, the ΨWT gRNA from the W35G NC mutant displayed a tight 
dimer profile similar to the ΨWT gRNA with wild type NC domains (Fig. 4-5).  This 
provides in vivo support that the W35G NC mutation specifically disrupts high affinity 
NC-RNA interactions required for dimer recruitment, but this mutation does not inhibit 
the low affinity NC-RNA interactions which likely function in dimer formation and 
stabilization. 
Dimer partner selection of packaged ΨM gRNAs is more random that ΨWT gRNAs. 
 If dimer partner selection acts as a mechanism for routing gRNAs towards sites of 
assembly and encapsidation, then the low level of gRNAs packaged by the dimer mutant 
ΨM would be expected to exhibit increased randomness in dimer partner associations.  




Figure 4-5. Non-denaturing northern blot analysis of the NC W35G mutant 
compared to wild type NCs containing ΨWT, ΨM, ΨΔCES, or Ψ-.  Nondenaturing 
northern blot of MLV gRNAs extracted from virions produced by transient transfection.  
Viral RNAs were either kept on ice prior to agarose gel electrophoresis or subjected to 
65ºC for 10 min.  Virus-containing media were normalized by RT activity to ensure the 
loading of RNA from an equivalent number of virions.  Migrations of either the tight WT 
gRNA dimer or the denatured gRNA monomer are indicated on the left. 
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random dimerization of MLV gRNAs expressed from a single locus (54) observed in 
previous studies suggest that dimer partner selection occurs early in the biogenesis of 
MLV gRNAs.  This implies that gRNA dimerization acts as an early mechanism for 
routing gRNAs towards sites of assembly.  Additionally, the increase in the randomness 
of gRNA dimerization that we observed upon transcription inhibition in studies described 
in Chapter III of this dissertation further argues that the majority of MLV gRNA dimer 
partner associations occur early.  In those studies, transcription inhibition disrupted the 
entire nascent pool of transcripts which comprise the earliest potential gRNAs capable of 
dimer partner associations, but it did not alter the ability of the gRNAs to form dimer 
partner associations later.     
 To test the prediction that disrupting gRNA dimerization would lead to an 
increase in the randomness of dimer partner associations, we performed RNA captures on 
gRNA dimers from virions produced by transient transfection with the ΨM dimer mutant 
(Fig. 4-6).  Data from two separate RNA captures showed a small but reproducible 
increase in the randomness of gRNA dimerization of the ΨM dimer mutant relative to 
ΨWT, from 1.84 to 1.58 with 1 being random (Fig. 4-6).  In these experiments, the level of 
nonrandomness exhibited by ΨWT gRNAs was lower than that reported in Chapter III 
here or in Flynn et al. (53).  However these results are preliminary.  The wash conditions 
used in the captures represented here were less stringent than those used in acquiring the 
data presented in Chapter III, and the variation in the stringency of wash conditions could 
account for the observed discrepancies.  While only a small increase in randomness was 
observed here, these trends are, nevertheless, consistent with the hypothesis that 
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disrupting the ability of MLV gRNAs to initially form dimers impairs their ability to be 




Figure 4-6. RNA capture measurement of the randomness of dimer partner 
associations in ΨM gRNAs versus ΨWT gRNAs.  (A) RPA of RNA capture of packaged 
ΨWT and ΨM gRNA dimers.  Mobilities of MLV and MΨPuro RNAs indicated on the 
right.  For each capture, input (i), flow through (ft), final wash (fw), and elution (e) are 
indicated on the top.  Lanes also include undigested probe (P); RNA size markers (M); 
and digested probe alone control (C). (B) elution ratios of ΨWT and ΨM quantified from 2 
separate RPAs of RNA captures normalized to 1 being the expected elution ratio from 




 The in vivo quantification of ΨM versus ΨWT-containing gRNA packaging 
supports an RNA switch model of gRNA recruitment.  The mutations in ΨM stabilize the 
stem loops of DIS-1 and the core encapsidation signal which disrupts dimerization and 
NC binding in vitro (124) and, as demonstrated here, inhibits gRNA packaging in vivo.  
Also, the inhibitory effect of ΨM mutations on gRNA dimerization led to a decreased 
thermal stability of ΨM-containing gRNA dimers in vivo.  This suggests that the defect in 
gRNA dimerization is causing the decrease in gRNA packaging, and it provides in vivo 
support for the model that gRNA dimerization switches the conformation of the gRNA to 
expose high affinity NC binding sites that recruit the gRNA into assembling virions. 
 The contribution of the zinc finger domain of NC to specific gRNA recruitment 
was also quantified here with an NC mutant that contained a disruption to the 
hydrophobic cleft in the zinc finger.  Virions with a W35G mutant NC domain packaged 
20-fold less ΨWT-containing gRNA than virions with a wild type NC domain.  Also, the 
hydrophobic cleft disruption of the NC domain had a two-fold greater defect in gRNA 
packaging than the cis-acting ΨM mutations.  In combination, virions produced from a 
double mutant of ΨM-containing gRNA and a W35G mutant NC packaged 10-fold less 
gRNA than single mutants with only ΨM mutations.  This suggests that the relatively 
efficient packaging of ΨM-containing gRNAs observed in virions produced by transient 
transfection is NC dependent.  It also provides in vivo support for the notion that the 
W35G NC mutation disrupts high affinity NC-RNA interactions which mediate specific 
gRNA recruitment but not low affinity NC-RNA interactions that might contribute to low 
level nonspecific RNA packaging by MLV. 
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 Observations from non-denaturing northern blot analysis of the W35G NC mutant 
further suggest that this residue of NC functions in specific gRNA recruitment and not 
other functions associated with low affinity interactions.  Functions of the NC domain of 
Gag include specific recruitment of MLV gRNAs and low affinity RNA interactions 
which function in catalyzing MLV gRNA dimerization (68, 162).  The tight dimer profile 
exhibited by gRNA isolated from virions produced with the W35G mutant suggests that 
this mutation is not disrupting the ability of the gRNAs to form strong dimer partner 
associations.  The effect of this mutation on high affinity gRNA recruitment and not low 
affinity dimer stabilization suggests that it could prove useful in disrupting other high 
affinity interactions that are necessary in retroviral replication.  For example, NC residues 
have been shown to play a role in viral DNA synthesis in vivo (71), and previous reports 
indicate that mutations to the same tryptophan residue abrogate virus spread (71, 72, 121).  
However, the results here suggest that transient overexpression could produce gRNA-
containing virions in sufficient quantity to study the impact of the W35G mutation on 
DNA synthesis in a single round of infection. 
 The ten-fold difference in ΨM gRNA packaging in virus produced by transient 
transfection versus single copy expression and competition experiments suggests that 
overexpression leads to non-specific incorporation of ΨM gRNAs.  Since virus particles 
produced without Ψ-containing RNAs package an excess of cellular mRNAs (132, 133), 
the elevated packaging of the ΨM mutant likely represents non-specific incorporation.  As 
mentioned above, the further decrease in packaging observed with the ΨM W35G double 
mutant suggests that this packaging of RNA is mediated by the NC zinc finger. 
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 The decreased packaging of the gRNA exhibited by the ΨM dimerization mutant 
is consistent with our model (Fig. 3-5) that gRNA dimer partner associations function in 
the initial recruitment of MLV gRNAs. The mutations of ΨM disrupt dimerization and 
therefore likely disrupt the early bisection of the unspliced RNA into separate fates of 
gRNA and mRNA.  To test for this impairment in nuclear gRNA dimerization and the 
predicted outcome that nonspecific incorporation of ΨM gRNAs should exhibit more 
random dimer partner associations, we performed an RNA capture experiment on 
packaged viral gRNAs produced from coexpressed ΨM mutants.  Our preliminary results 
indicate that ΨM gRNAs associated more randomly which is consistent with predictions 
based on our model.  However, the difference was small relative to ΨWT internal controls.  
Subsequent to these experiments, modifications to the RNA capture procedure have 
reproducibly produced levels of nonrandom ΨWT gRNA dimerization that are two-fold 
greater than those obtained here (Fig. 3-2A and C, pre-ActD and –DRB treatments).  
Incorporating these procedural modifications to an analysis of ΨM dimerization could 
bolster the small change in randomness seen here, with the expectation that ΨWT gRNAs 
would exhibit about two-fold greater levels of nonrandomness and the more random 
associations of ΨM-containing gRNAs wouldn’t display a parallel increase in 
nonrandomness. 
 MLV ΨWT has been previously demonstrated to function in the nuclear egress and 
intracellular localization of MLV unspliced RNAs, and the participation of Ψ in gRNA 
dimerzation may, therefore, also regulate these aspects of MLV RNA trafficking (7, 192).  
Levels of virion production for ΨM-containing provirus constructs were comparable to 
ΨWT which suggests that MLV unspliced RNAs with either Ψ were efficiently exported 
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from the nucleus and trafficked to sites of viral mRNA translation.  However, the 
inefficient packaging of ΨM gRNA could also indicate aberrant gRNA intracellular 
localization.  In the context of our model of MLV unspliced RNA nuclear dimerization 
and corresponding bisection in RNA fates (Fig. 3-5), the impaired ability of ΨM to form 
dimers might alter the manner of its nuclear egress.  Recent results in HIV-1 demonstrate 
that nuclear egress of coexpressed unspliced RNAs via separate host cell pathways 
disrupts normal random dimer partner associations (128).  If ΨM gRNAs are exiting the 
nucleus via an alternate pathway than dimeric ΨWT gRNAs, then co-expression of ΨWT 
with ΨM gRNAs might be expected to exhibit even greater levels of nonrandomness in 
dimer partner associations.  The opposite result of increase randomness between ΨWT and 
ΨM might be consistent with the nonspecific incorporation of ΨM gRNAs and inconsistent 
with the hypothesis that dimeric gRNAs and monomeric viral unspliced RNAs traffic to 




CONCLUSIONS AND FUTURE DIRECTIONS 
OVERVIEW 
 Results presented in this dissertation suggest that MLV recruits cellular and viral 
RNAs from the host cell nucleus.  Chapter II observations of MLV high level mY RNA 
packaging and mY RNA intracellular redistribution suggest that mY RNAs are recruited 
early in their biogenesis in the nucleus, which is consistent with prior findings of high 
level mY RNA recruitment from Ro60 knockout cells by Onafuwa-Nuga (148).  Data 
presented in Chapter II were obtained in collaboration with the Sandra Wolin lab at Yale 
University and published in Garcia et al. (65).  Chapter III results support the nuclear 
bisection in MLV unspliced RNAs into mRNA or gRNA functions.  Observations in 
Chapter III are consistent with the hypothesis that MLV gRNAs form nuclear dimer 
partner associations and suggest a subset of MLV unspliced RNAs, which escape dimer 
partner associations at or near sites of transcription, may disproportionately contribute to 
heterozygous virions.  Results in Chapter IV that demonstrate the ~100-fold reductions in 
MLV packaging of ΨM-containing gRNAs, which contain Ψ stem loop stabilizing 
mutations which disrupt dimerization and NC binding in vitro, are consistent with an 
RNA switch model of MLV gRNA recruitment, and preliminary observations suggest 
that this gRNA dimerization-dependent switch functions in nuclear gRNA recruitment by 
MLV.  Chapter IV results were obtained in collaboration with the Mike Summers lab at 
the University of Maryland Baltimore County and published in Miyazaki et al. (124).   
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Together, the findings of nuclear recruitment of viral gRNAs and cellular mY RNAs 
suggest a potential intersection in MLV replication with a cellular RNA quality control 
pathway. 




• MLV expressed in wild type MEFs packages 3 to 5 copies of mY1 and mY3 RNAs 
each, and MLV expressed in Ro60 knockout cells packages ~2 copies each of mY1 and 
mY3 RNAs. 
 
• Levels of mY RNAs in Ro60 knockout cells are redistributed more evenly between the 
nucleus and the cytoplasm than in wild type cells where the majority of mY RNAs are 
cytoplasmic. 
 
• MLV recruitment of mY RNAs occurs independent of mY RNA 3’ end maturation. 
 




• Specific repression of MLV transcription leads to a more rapid decline in gRNA 
packaging than virion production. 
 
• The randomness of co-expressed MLV gRNA dimer partner associations increases over 
time after general transcription inhibition. 
 
• An increase in the frequency of recombination between co-expressed MLV gRNAs 
parallels the increase in the randomness of gRNA dimerization after general transcription 
inhibition. 
 
• gRNA co-packaging and the frequency of recombination between co-expressed MLV 




• Mutations that stabilize MLV Ψ stem loops and inhibit dimerization and nucleocapsid 
(NC) binding in vitro decrease gRNA packaging into MLV by 100-fold in a tissue culture 
system of single-copy integrated proviruses. 
 
• Quantification of MLV gRNA packaging in virus produced by transient transfection 




• Packaged MLV gRNAs which contain Ψ deletions or Ψ stem loop stabilizing mutations 
exhibit reduced thermal stability compared to gRNAs with wild type Ψs. 
 
• Disruption of a hydrophobic cleft in MLV NC decreases MLV gRNA packaging by 20-
fold compared to MLV with a wild type NC in a transient transfection tissue culture 
system. 
 
• MLV gRNAs packaged by a hydrophobic cleft NC mutant exhibit wild type dimer 
mobility on non-denaturing gels. 
 
• Packaged MLV gRNAs with Ψ stem loop stabilizing mutations exhibit slightly 





 In Ro60 knockout cells, the cellular mY1 and mY3 RNAs are more highly 
recruited by MLV than the retroviral gRNA.  Ro60 knockout cells contain ~30-fold less 
mY1 RNAs than wild type cells, and the mY1 RNA levels in knockout cells are 
redistributed more evenly between the nucleus and the cytoplasm.  This redistribution 
shifts the levels of mY RNAs away from cytoplasmic sites of MLV assembly on the 
plasma membrane.  The continued packaging of high levels of mY RNAs from Ro60 
knockout cells suggests that mY RNAs are actively recruited by MLV from the host cell 
nucleus at an early stage in their biogenesis. 
Chapter III 
 Specific repression of MLV transcription reveals a similar bisection in MLV 
unspliced RNA fates as that previously seen when transcription is inhibited with 
actinomycin D (ActD).  Tetracycline-regulated repression of MLV transcription leads to 
a more rapid decline in MLV gRNA packaging than virion production.  This result is 
consistent with previous findings using ActD (107) which suggest that MLV gRNAs sort 
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into separate non-equilibrating pools of viral mRNAs and gRNAs.  However, the 
decrease in MLV gRNA packaging upon specific repression of MLV transcription is less 
than that seen with ActD.  This suggests either that the tetracycline-regulated repression 
of MLV transcription is incomplete or that ActD treatment disrupts an additional 
component of MLV gRNA recruitment, possibly by sequestering or re-localizing viral 
and/or cellular factors required for gRNA recruitment. 
 Transcription inhibition leads to increases in the randomness of MLV gRNA 
dimer partner selection and recombination over time in co-expression assays.  Results 
presented in this dissertation are consistent with previous results that demonstrated that 
the majority of MLV gRNAs expressed from separate nuclear loci preferentially self-
associate (53).  However, the increases in the randomness of gRNA dimerization and 
frequency of recombination that occur concurrent with decreases in gRNA packaging 
after transcription inhibition suggest that some MLV gRNAs are forming dimer partner 
associations more randomly.  This subset of MLV gRNAs may contribute 
disproportionately to the number of heterodimers packaged by MLV in coexpression 
studies. 
Chapter IV 
 MLV gRNA dimerization functions in the subsequent recruitment of the dimeric 
gRNA into MLV particles.  Disrupting MLV gRNA dimer formation abrogates gRNA 
recruitment into MLV particles.  Mutations to Ψ that stabilize Ψ-associated stem loops 
and inhibit RNA dimerization and NC binding in vitro disrupt gRNA packaging in vivo.  
These results support an RNA switch model of MLV gRNA recruitment.  In this model, 
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dimerization switches MLV gRNA to a fold that exposes high affinity NC binding sites 
which then recruit the dimeric gRNA into MLV particles. 
 The hydrophobic cleft in MLV NC functions in gRNA recruitment but not gRNA 
dimerization.  Substitution of a tryptophan with an alanine residue at amino acid 35 in 
MLV NC (W35G) disrupts gRNA packaging but not gRNA dimerization.  This W35G 
mutant NC decreases packaging by 20-fold compared to wild type NC, but the gRNA 
packaged into W35G NC mutant particles exhibits wild type dimer mobility on non-
denaturing gels.  This suggests that this mutant NC is defective in high affinity RNA 
binding but not low affinity RNA chaperone activity. 
 PRELIMINARY DATA AND FUTURE DIRECTIONS 
 The nuclear recruitment of MLV gRNAs and cellular noncoding mY RNAs 
suggests an intersection in MLV ribonucleoprotein (RNP) assembly with a cellular RNA 
quality control pathway.  Emerging evidence suggests that Y RNAs function together 
with the Ro60 protein in the recognition of misfolded noncoding RNAs within the host 
cell nucleus (171).  Data presented in this dissertation suggest that mY RNAs and MLV 
gRNA are recruited by MLV from the same subcellular compartment: the host cell 
nucleus.  This Chapter will present additional preliminary data which further support this 
intersection and future directions to explore this. 
Decreased gRNA packaging leads to increased mY1 RNA packaging by MLV 
 Increased packaging of human hY RNAs has been reported in human 
immunodeficiency virus type 1 (HIV-1) particles produced by a 5’ UTR-deleted helper 
construct that packages undetectable levels of HIV-1 gRNA (91).  HIV-1 virions with 
wild type 5’-UTRs package very low levels of Y RNAs (148).  This suggests potential 
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differences in the RNP formation and Y RNA recruitment in HIV-1 versus MLV, since 
the latter packages high levels of Y RNAs.  The increased packaging of hY RNAs by 
HIV-1 virions with reduced levels of gRNA suggests competition between gRNA and Y 
RNA recruitment.  Despite the demonstrated differences in Y RNA recruitment by HIV-1 
and MLV, we sought to test for similar competition in Y RNA and gRNA recruitment in 
MLV. 
To determine if decreased levels of gRNA packaging correlated with more mY1 
RNA packaging, MLV mY1 RNA packaging was analyzed in virus produced with ΨM-
containing proviruses in a transient transfection system.  MLV packages approximately 
12-fold less ΨM-containing gRNAs, which contain Ψ stem loop stabilizing GNRA 
mutations (G, guanosine; N, any nucleotide; R, purine; and A, adenosine) that disrupt 
dimerization and NC binding in vitro, than ΨWT-containing gRNAs in transient 
transfection experiments (as quantified in Chapter IV).  However, MLV virions produced 
from ΨM-containing proviruses packaged nearly two-fold more mY1 RNAs than virions 
produced from ΨWT-containing proviruses (Fig. 5-1).  This result is demonstrated by a 
non-denaturing northern blot that was first probed for mY1 and subsequently stripped and 
re-probed for 7SL to normalize for the number of virions (Fig. 5-1).  Quantification of 
total mY1 RNA per total 7SL RNA for each lane revealed an approximately two-fold 
increase in mY1 RNA packaging in the ΨM mutant (Fig. 5-1).  These data are consistent 
with the earlier results with HIV-1 (212) and suggest MLV gRNA recruitment may 
intersect with MLV mY RNA recruitment. 
The increased packaging of hY RNAs by particles produced from HIV-1 5’-UTR 
deleted helper constructs was reported to be NC dependent (91).  Khan et al. (91) used an 
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HIV-1 NC double mutant, in which the zinc-chelating cysteine residues of both zinc 
fingers had been replaced by serine residues, to test for the NC dependence of hY RNA 
packaging.  RT-PCR levels of hY RNAs were below the limit of detection in particles 
produced from their NC double mutant (91).  This suggested to the authors that the 
increased hY RNA recruitment into HIV-1 particles produced from the 5’-UTR deleted 
helper was NC dependent. 
To determine if mY1 RNA packaging was increased in MLV virions with Ψ 
deletions, mY1 RNA packaging was analyzed in MLV virions produced by proviral 
constructs containing Ψ deletions.  Using the core encapsidation signal (ΨΔCES) and the 
“classic” Ψ deletion (Ψ-) described in Chapter IV, which packaged ~100-fold less MLV 
gRNA by transient transfection, mY1 RNA packaging was assessed by nondenaturing 
northern blot.  Results show that mY1 RNA packaging in virions generated from Ψ 
deletion expression constructs was increased to a similar extent (~two-fold) as that 
observed with the ΨM mutant (Fig. 5-2, lanes 1 through 8).  These data are consistent 
with those of Khan et al. (91) for the HIV-1 5’-UTR deleted helper virus, and they also 
demonstrate that large reductions in MLV gRNA packaging lead to increases in mY 
RNA packaging (Fig. 5-2, lanes 1 through 8 and Chapter IV Fig. 4-1B and 1C).  The two-
fold increase in mY1 RNA packaging in virions with large reductions in gRNA 
packaging suggests that mY RNA recruitment may intersect with gRNA recruitment and 
MLV assembly.  Also, this inverse relationship in mY RNA and gRNA packaging may 






Figure 5-1.  Nondenaturing northern analysis of mY1 (top) and 7SL (bottom) of 
viral RNA from MLV with ΨWT- or ΨM-containing proviruses.  RNA extracted from 
virions was probed for mY1 RNAs (top) stripped and reprobed for 7SL RNAs (bottom).  
Arrows indicate the co-migration of mY1 and 7SL RNAs with viral gRNAs.  Arrowheads 
indicate the mobility of mY1 and 7SL RNAs that are not annealed to longer RNAs. 
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Next, to determine if the recruitment of mY RNAs into MLV particles is NC 
dependent, mY1 RNA packaging was analyzed with the W35G hydrophobic cleft NC 
mutant that disrupts high affinity NC-RNA interactions.  Results demonstrate that mY 
RNA packaging in the MLV W35G NC mutant was comparable to that in MLV virions 
with wild type NC (Fig. 5-2, lanes 1 and 2 and lanes 9 and 10).  This suggests that mY 
RNAs do not compete with gRNAs for high affinity NC binding.  However, it remains 
possible that mY RNAs are recruited by low affinity NC-RNA interactions.   
Future directions to address the potential intersection in mY RNA recruitment 
with MLV gRNA recruitment could build upon these preliminary data.  The results 
presented in Figures 5-1 and 5-2 were obtained by nondenaturing northern blots which, 
because of differences in the specific activities of separate probes for mY1 and 7SL, are 
not as quantitative as RNase protection assays.  RNAse protection assays also have the 
potential to be more sensitive which could reveal subtle differences in mY1 RNA 
packaging that are not evident by northern blot analysis.  Such approaches could assess 
differences in mY RNA recruitment into virions from ΨM versus Ψ deletion-containing 
constructs which differ in gRNA packaging by as much as 10-fold in transient 
transfection experiments.  Also, measuring differences in mY RNA packaging into 
virions produced by single-copy integrated proviruses could provide a more biologically 
relevant measurement of differences between MLV mY RNA recruitment into virions 
from ΨWT versus ΨM-containing gRNAs. 
Speculatively, the results indicating wild type levels of mY RNA packaging by 
the W35G NC mutant may suggest that low affinity NC-RNA interactions are involved in 





Figure 5-2. .  Nondenaturing northern analysis of mY1 (top) and 7SL (bottom) of 
viral RNA from MLV particles containing:  wild type NC with ΨWT, ΨM, ΨΔCES, or 
Ψ- gRNAs or the W35G mutant NC with ΨWT gRNAs.  RNA extracted from virions 
was probed for mY1 RNAs (top) stripped and reprobed for 7SL RNAs (bottom).  Blots 
on the right are overexposure of the same blots on the left.  Arrows indicate the co-
migration of mY1 and 7SL RNAs with viral gRNAs (Fig. 4-5).  Black arrowheads 
indicate the mobility of mY1 and 7SL RNAs that are not annealed to longer RNAs.  The 
gray arrowheads indicate a band of intermediate mobility between free noncoding RNAs 
and noncoding RNAs annealed to the retroviral gRNA.  In addition to the results 
mentioned in the text, the lack of visible mY1 and 7SL RNAs co-migrating with 
packaged MLV gRNAs in the W35G mutant serves as a negative control for cross-
hybridization of the probes used here with the retroviral gRNA. 
 126
 
quantified using additional NC mutants that disrupt low affinity NC-RNA interactions, 
both by NC zing finger disruptions and by disruptions to the two basic regions 
surrounding the NC zinc finger.  Onafuwa-Nuga (148) observed a reproducible two-fold 
decrease in 7SL packaging in NC basic region mutants.  This suggests that NC low 
affinity RNA chaperone activity may function to a limited extent in 7SL RNA 
recruitment.  To address the mechanism of 7SL recruitment, our lab is currently studying 
7SL and 7SL-derivative RNA packaging in HIV-1-derived minimal VLPs (Keene and 
Telesnitsky, in preparation).  These minimal VLPs contain a leucine zipper motif in 
place of HIV-1 NC, to mediate protein-protein interactions required in particle assembly 
(1).  The design and testing of RNA packaging with a similar mutant in MLV could aid in 
determining whether or not MLV NC functions in mY RNA recruitment. 
 Nondenaturing northern blot analysis of mY1 and 7SL RNAs packaged by the 
MLV W35G NC mutant revealed a couple of intriguing observations that could be 
further tested (Fig. 5-2).  First, the W35G mutant disrupted MLV gRNA packaging but 
not MLV gRNA dimerization, as demonstrated when the blot shown in Fig. 5-2 was 
probed with an oligo complementary to the R-region (Fig. 4-5).  In contrast to wild type, 
no mY1 RNA or 7SL RNA co-migrated with the dimeric or denatured-monomeric gRNA 
for this mutant.  This may suggest that when NC binds to gRNA with high affinity it 
concurrently traps some molecules of mY1 and 7SL.  These RNAs then continue to 
anneal to the gRNA during RNA extraction from virions and subsequently migrate with 
the gRNA on nondenaturing gels (Fig. 5-2 and Fig. 4-5).  Basic residue substitutions in 
MLV NC that preserve high affinity interactions but reduce RNA chaperone activity 
could be used to test this hypothesis.  The MLV NC domain is highly basic, and this 
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basic nature may function in an RNA chaperone capacity (170).  Substitution of basic 
residues in and around the NC zinc finger (e.g. K30A) has been demonstrated to disrupt 
replication (71) and 7SL packaging (148), and these mutations could provide a starting 
point for testing outcomes of NC RNA chaperone disruption on noncoding RNA 
packaging.  Expectations consistent with this hypothesis would entail mY and 7SL RNAs 
migrating with the gRNA in nondenaturing northern blots and potentially lower total mY 
and 7SL RNA packaging in low affinity-disrupted MLV NC mutants.  Alternatively, low 
affinity-disrupted mutants might display a similar phenotype to the W35G mutant and 
contain no or less mY and 7SL co-migrating with MLV gRNA.  Such an outcome would 
suggest that both low and high affinity NC-RNA interactions function in the annealing of 
noncoding cellular RNAs to the viral gRNA.  
 Second, overexposure of the nondenaturing northern blot of 7SL RNA revealed a 
band that had an intermediate mobility (Fig. 5-2, bottom right, lane 19, gray arrowhead) 
between the faster migrating majority of 7SL RNAs (Fig. 5-2, bottom left, lane 9, black 
arrow head) and the slower migrating dimeric gRNA bands (Fig. 5-2, black arrow and 
Fig. 4-5).  This band was not evident upon probing for the viral gRNA with the anti-R 
region probe that was used in Chapter IV (Fig. 4-5).  Speculatively, this could indicate 
elevated packaging of a cellular RNA by the W35G mutant.  The annealing of 7SL to this 
RNA might occur in a manner distinct from how 7SL anneals to the viral gRNA.   
Alternatively, the W35G NC mutant might alter the intracellular localization of 
Gag which would disrupt nuclear recruitment of MLV gRNAs and concurrent nuclear 
recruitment of noncoding cellular RNAs.  This hypothesis asserts that a portion of Gag 
traffics through the nucleus, where it recruits RNA en route to sites of assembly.  If this 
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alternative speculation is correct, the co-migration of 7SL and mY RNAs with MLV 
gRNAs might provide further support for the model of nuclear RNA recruitment 
proposed in this hypothesis.  Analysis of the intracellular localization of the W35G NC 
mutant Gag compared to wild type Gag by either immunofluorescence or GFP-tagged 
molecules could provide a means of testing this hypothesis.  Because this hypothesis 
speculates that MLV Gag is recruiting RNA in the nucleus, slowing RNA nuclear export 
machinery might aid in attempts to observe wild type of W35G mutant Gag nuclear 
localization.  In combination with fluorescent microscopy of the Gag molecules, host cell 
RNA nuclear export machinery could be slowed or perturbed with drugs, dominant 
negatives, RNAi, or RNA competitors, and host cell nuclei could be monitored for wild 
type and W35G Gag co-localization.   
Analyzing the randomness of gRNA dimer partner associations with the W35G 
mutant NC could also address this question of potential mis-localization of W35G mutant 
Gag molecules.  If the W35G mutant Gag does not translocate to the nucleus, it could not 
function in nuclear gRNA recruitment.  Thus, gRNAs packaged into W35G mutant 
virions would likely be recruited from the cytoplasm and be expected to display increased 
randomness in gRNA dimer partner associations.  As detailed by the methodology in 
Chapter III, this hypothesis could be tested by both biochemical RNA capture assays and 
genetic recombination assays. 
A nuclear intersection of MLV gRNA recruitment with a host cell noncoding 
RNA quality control pathway might be expected to perturb the intracellular localization 
of components of the cellular RNA quality control pathway.  To determine if MLV 
infection altered the subcellular localization of mY RNAs, mock and chronically-infected 
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NIH-3T3 cells were fractionated and analyzed by northern blot.  MLV infection did not 
alter the nuclear to cytoplasmic distribution of mY1 RNAs (Fig. 5-3A, time 0 and mock).  
However, high level recruitment of mY RNAs by MLV in cells with or without the Ro60 
protein suggests that these RNAs are recruited early in their biogenesis by MLV.  
Because prior studies have indicated that mY RNAs normally translocate and localize to 
the cytoplasm with the Ro60 protein in uninfected cells (164), the nuclear recruitment of 
mY RNAs by MLV might be expected to disrupt the normal subcellular localization of 
Ro60.  The localization of Ro60 could be monitored by immunofluorescence in mock and 
chronically-infected cells, or its subceullar distribution in these cells could be determined 
by fractionation and subsequent western blots. 
Lastly, in Chapter III, attempts to determine the relative half-life of nuclear 
unspliced MLV RNA were complicated by the global effects of general transcription 
inhibition with actinomycin D.  A wide range of cellular noncoding RNAs were 
monitored for use as controls for Chapter III Figure 3-4 (Fig. 5-3A and 3B).  General 
transcription inhibition with actinomycin D led to decreased cytoplasmic levels of all the 
non-coding RNAs tested (Fig. 5-3).  Future experiments to determine the nuclear half-life 
of MLV unspliced RNA could use the tetracycline-inducible MLV cells also described in 
Chapter III.  Specific repression of MLV transcription would not be expected to alter the 
intracellular distribution of cellular noncoding RNA which could then be used as controls 
for sample loading.  Also, alterations in noncoding cellular RNA packaging after 
tetracycline-regulated repression of MLV might imply either co-recruitment with MLV 
gRNA or competition with MLV gRNA for recruitment.  If non-competitive co-
recruitment is occurring, then tetracycline-regulated repression of MLV would be 
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expected to result in a decrease in packaging of this RNA.  Alternatively, repression of 
MLV transcription would be expected to increase packaging of RNAs which compete 






Figure 5-3. Northern blot of total, nuclear, and cytoplasmic fractions from NIH 3T3 
fibroblasts that are mock or chronically-infected with MLV (M/M).  (A) Total (T), 
nuclear (N), and cytoplasmic (C) fractions were probed for mY1 (Y1) RNAs, U6 
snRNAs, 7SL RNAs, and mitochondrial tRNAs.  (B)  Nuclear and cytoplasmic fractions 
probed for U1 snRNA, 5S rRNA, tRNALys1, 28S rRNA, and 5.8S rRNA.  M/M cells are 
NIH 3T3 cells that are chronically infected with MLV.  Mock cells were uninfected NIH 
3T3 cells.  The time in hours pre- and post-actinomycin D treatment is indicated on the 
top.  Fractions were obtained by methods described in Chapter II and III which used 
digitonin to permeabilize the plasma membrane.  Figures A and B represent two different 
blots that were repetitively stripped and re-probed for the indicated noncoding RNAs.  On 
the right of each blot is an RNA size marker (M).  The co-fractionation of mitochondrial 
tRNA with the nuclear fraction suggests that mitochondria were retained in the nuclear 
fraction, and this also suggests that the permeabilization of the plasma membrane with 
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